{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:48:36Z","timestamp":1792172916134,"version":"4.4.0"},"reference-count":573,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009391","name":"University of Tabuk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009391","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.drup.2025.101326","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T01:33:46Z","timestamp":1763084026000},"page":"101326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Ferroptosis and the cGAS\u2013STING pathway into precision nano-immuno-theranostics: A mechanistic paradigm for reversing drug resistance in hepatocellular carcinoma"],"prefix":"10.1016","volume":"84","author":[{"given":"Alaa","family":"Elmetwalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2025.101326_bib1","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat8657","article-title":"cGAS in action: expanding roles in immunity and inflammation","volume":"363","author":"Ablasser","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.drup.2025.101326_bib2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMoa1717002","article-title":"Cabozantinib in patients with advanced and progressing hepatocellular carcinoma","volume":"379","author":"Abou-Alfa","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2025.101326_bib3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.18579\/jopcr\/v23.1.24","article-title":"Advanced applications of artificial intelligence in pharmacovigilance: current trends and future perspectives","volume":"23","author":"Ahire","year":"2024","journal-title":"J. Pharm. Res"},{"key":"10.1016\/j.drup.2025.101326_bib4","doi-asserted-by":"crossref","first-page":"19386","DOI":"10.1073\/pnas.1215006109","article-title":"STING manifests self DNA-dependent inflammatory disease","volume":"109","author":"Ahn","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.drup.2025.101326_bib5","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1038\/ncomms6166","article-title":"Inflammation-driven carcinogenesis is mediated through STING","volume":"5","author":"Ahn","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101326_bib6","article-title":"Molecular mediators of metabolic reprogramming in cancer: mechanisms, regulatory networks, and therapeutic strategies","author":"Ahuja","year":"2025","journal-title":"Immunology"},{"key":"10.1016\/j.drup.2025.101326_bib7","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","article-title":"The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015","volume":"3","author":"Akinyemiju","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.drup.2025.101326_bib8","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41375-023-02117-2","article-title":"Mitochondrial regulation of GPX4 inhibition\u2013mediated ferroptosis in acute myeloid leukemia","volume":"38","author":"Akiyama","year":"2024","journal-title":"Leukemia"},{"key":"10.1016\/j.drup.2025.101326_bib9","doi-asserted-by":"crossref","DOI":"10.1021\/acsanm.5c03463","article-title":"Review of chitosan-coated nanoscale liposomes for enhanced drug delivery","author":"Alcantara","year":"2025","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.drup.2025.101326_bib10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2174\/1567201819666220126163943","article-title":"Nanotechnology-based medicinal products and patents: a promising way to treat psoriasis","volume":"19","author":"Ali","year":"2022","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.drup.2025.101326_bib11","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nbt.2284","article-title":"Combinatorial drug therapy for cancer in the post-genomic era","volume":"30","author":"Al-Lazikani","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.drup.2025.101326_bib12","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","article-title":"Comprehensive and integrative genomic characterization of hepatocellular carcinoma","volume":"169","author":"Ally","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.drup.2025.101326_bib13","first-page":"1","article-title":"AI-driven biomarker discovery: enhancing precision in cancer diagnosis and prognosis","volume":"16","author":"Alum","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.drup.2025.101326_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-025-00844-5","article-title":"Molecular network of metabolic reprogramming and precision diagnosis and treatment of hepatocellular carcinoma","volume":"13","author":"An","year":"2025","journal-title":"Biomark. Res."},{"key":"10.1016\/j.drup.2025.101326_bib15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.omtn.2018.11.003","article-title":"An analysis of the expression and association with immune cell infiltration of the cGAS\/STING pathway in pan-cancer","volume":"14","author":"An","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.drup.2025.101326_bib16","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1093\/annonc\/mdu478","article-title":"Prioritizing targets for precision cancer medicine","volume":"25","author":"Andre","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.drup.2025.101326_bib17","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.bbagen.2010.02.005","article-title":"Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage","volume":"1800","author":"Arosio","year":"2010","journal-title":"Biochim. Biophys. Acta (BBA)Gen. Subj."},{"key":"10.1016\/j.drup.2025.101326_bib18","doi-asserted-by":"crossref","first-page":"1900221","DOI":"10.1002\/bies.201900221","article-title":"Spatially resolved transcriptomes-next generation tools for tissue exploration","volume":"42","author":"Asp","year":"2020","journal-title":"BioEssays"},{"key":"10.1016\/j.drup.2025.101326_bib19","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jconrel.2011.06.001","article-title":"Targeted drug delivery to tumors: myths, reality and possibility","volume":"153","author":"Bae","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drup.2025.101326_bib20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature25432","article-title":"Chromosomal instability drives metastasis through a cytosolic DNA response","volume":"553","author":"Bakhoum","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.drup.2025.101326_bib21","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nri3921","article-title":"STING: infection, inflammation and cancer","volume":"15","author":"Barber","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.drup.2025.101326_bib22","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1359-0294(00)00090-X","article-title":"Liposome application: problems and prospects","volume":"6","author":"Barenholz","year":"2001","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"10.1016\/j.drup.2025.101326_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae The first FDA-approved nano-drug: Lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drup.2025.101326_bib24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/chemengineering9030056","article-title":"Liposome-based drug delivery systems: from laboratory research to industrial production-instruments and challenges","volume":"9","author":"Basak","year":"2025","journal-title":"ChemEngineering"},{"key":"10.1016\/j.drup.2025.101326_bib25","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/nm.4409","article-title":"Cancer stem cells revisited","volume":"23","author":"Batlle","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.drup.2025.101326_bib26","first-page":"720","article-title":"FDA and nanotech: baby steps lead to regulatory uncertainty","author":"Bawa","year":"2013","journal-title":"Bio Nanotechnol. A Revolut. Food Biomed. Heal. Sci."},{"key":"10.1016\/j.drup.2025.101326_bib27","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nrc3130","article-title":"A decade of exploring the cancer epigenome-biological and translational implications","volume":"11","author":"Baylin","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2025.101326_bib28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nrclinonc.2011.165","article-title":"Adaptive clinical trials in oncology","volume":"9","author":"Berry","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101326_bib29","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.drup.2025.101326_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/hep.26350","article-title":"lu, S. Imbeaud, O. Maurhofer, P. Bioulac Sage, J. Zucman Rossi, J.F. Dufour, J.R. Idle, Tissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classification","volume":"58","author":"Beyo","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.drup.2025.101326_bib31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12943-025-02337-3","article-title":"Reprogrammed immuno-metabolic environment of cancer: the driving force of ferroptosis resistance","volume":"24","author":"Bhowmick","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2025.101326_bib32","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s12325-018-0805-y","article-title":"Interpretation and impact of real-world clinical data for the practicing clinician","volume":"35","author":"Blonde","year":"2018","journal-title":"Adv. Ther."},{"key":"10.1016\/j.drup.2025.101326_bib33","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40658-015-0109-0","article-title":"Effects of ferumoxytol on quantitative PET measurements in simultaneous PET\/MR whole-body imaging: a pilot study in a baboon model","volume":"2","author":"Borra","year":"2015","journal-title":"EJNMMI Phys."},{"key":"10.1016\/j.drup.2025.101326_bib34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40290-020-00332-1","article-title":"Establishing patient registries for rare diseases: rationale and challenges","volume":"34","author":"Boulanger","year":"2020","journal-title":"Pharm. Med."},{"key":"10.1016\/j.drup.2025.101326_bib35","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/s41467-021-21615-4","article-title":"Inter-and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling","volume":"12","author":"Brady","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101326_bib36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(16)32453-9","article-title":"Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"389","author":"Bruix","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.drup.2025.101326_bib37","first-page":"1","article-title":"Iron metabolism and the tumor microenvironment: a new perspective on cancer intervention and therapy","volume":"55","author":"Bu","year":"2025","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.drup.2025.101326_bib38","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1158\/0008-5472.CAN-10-2820","article-title":"The efficacy of radiotherapy relies upon induction of type I interferon-dependent innate and adaptive immunity","volume":"71","author":"Burnette","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.drup.2025.101326_bib39","first-page":"998","article-title":"Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanoma","volume":"9","author":"Butterfield","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2025.101326_bib40","article-title":"Guideline on risk management systems for medicinal products for human use","author":"C. for M.P. for H. Use","year":"2005","journal-title":"Lond. Eur. Med. Agency"},{"key":"10.1016\/j.drup.2025.101326_bib41","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41587-021-00830-w","article-title":"Robust decomposition of cell type mixtures in spatial transcriptomics","volume":"40","author":"Cable","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.drup.2025.101326_bib42","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nnano.2011.166","article-title":"Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size","volume":"6","author":"Cabral","year":"2011","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.drup.2025.101326_bib43","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2017.05.014","article-title":"Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification","volume":"67","author":"Calderaro","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.drup.2025.101326_bib44","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/1535370217750088","article-title":"Biomarker definitions and their applications","volume":"243","author":"Califf","year":"2018","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.drup.2025.101326_bib45","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1200\/JCO.1989.7.11.1748","article-title":"Carboplatin dosage: prospective evaluation of a simple formula based on renal function","volume":"7","author":"Calvert","year":"1989","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101326_bib46","doi-asserted-by":"crossref","first-page":"17267","DOI":"10.1021\/acsnano.4c04901","article-title":"Lipid Nanoparticular Codelivery System for Enhanced Antitumor Effects by Ferroptosis-Apoptosis Synergistic with Programmed Cell Death-Ligand 1 Downregulation","volume":"18","author":"Cao","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.drup.2025.101326_bib47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0016-5085(03)00689-9","article-title":"Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma","volume":"125","author":"Capurro","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drup.2025.101326_bib48","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jconrel.2019.02.030","article-title":"Measuring particle size distribution of nanoparticle enabled medicinal products, the joint view of EUNCL and NCI-NCL. A step by step approach combining orthogonal measurements with increasing complexity","volume":"299","author":"Caputo","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drup.2025.101326_bib49","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1021\/cr980440x","article-title":"Gadolinium (III) chelates as MRI contrast agents: structure, dynamics, and applications","volume":"99","author":"Caravan","year":"1999","journal-title":"Chem. Rev."},{"key":"10.1016\/j.drup.2025.101326_bib50","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.drup.2025.101326_bib51","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/emboj.2013.86","article-title":"Species-specific detection of the antiviral small-molecule compound CMA by STING","volume":"32","author":"Cavlar","year":"2013","journal-title":"EMBO J."},{"key":"10.1016\/j.drup.2025.101326_bib52","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.stem.2021.02.011","article-title":"Mitochondria as signaling organelles control mammalian stem cell fate","volume":"28","author":"Chakrabarty","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.drup.2025.101326_bib53","doi-asserted-by":"crossref","DOI":"10.1039\/D5NA00032G","article-title":"A Review of Emerging Trends in Nanomaterial-Driven AI for Biomedical Application","author":"Chakroborty","year":"2025","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.drup.2025.101326_bib54","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1021\/ar700108g","article-title":"Targeted cancer therapy: conferring specificity to cytotoxic drugs","volume":"41","author":"Chari","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.drup.2025.101326_bib55","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3390\/cancers17030392","article-title":"Hepatic iron overload and hepatocellular carcinoma: new insights into pathophysiological mechanisms and therapeutic approaches","volume":"17","author":"Chatzikalil","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.drup.2025.101326_bib56","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaa6090","article-title":"Spatially resolved, highly multiplexed RNA profiling in single cells","volume":"348","author":"Chen","year":"2015","journal-title":"Science (80. )"},{"key":"10.1016\/j.drup.2025.101326_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102644","article-title":"Overcoming sorafenib treatment-resistance in hepatocellular carcinoma: a future perspective at a time of rapidly changing treatment paradigms","volume":"52","author":"Chen","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.drup.2025.101326_bib58","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41419-023-05716-0","article-title":"The interaction between ferroptosis and inflammatory signaling pathways","volume":"14","author":"Chen","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drup.2025.101326_bib59","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1021\/ar200231d","article-title":"Theranostic nanomedicine","volume":"44","author":"Chen","year":"2011","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.drup.2025.101326_bib60","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1039\/D0BM01617A","article-title":"Orchestration of biomimetic membrane coating and nanotherapeutics in personalized anticancer therapy","volume":"9","author":"Chen","year":"2021","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.drup.2025.101326_bib61","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.drup.2025.101326_bib62","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1021\/acs.chemrev.5b00148","article-title":"Nanochemistry and nanomedicine for nanoparticle-based diagnostics and therapy","volume":"116","author":"Chen","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.drup.2025.101326_bib63","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni.3558","article-title":"Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing","volume":"17","author":"Chen","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.drup.2025.101326_bib64","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2014.09.025","article-title":"Development of lipid nanoparticle formulations of siRNA for hepatocyte gene silencing following subcutaneous administration","volume":"196","author":"Chen","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drup.2025.101326_bib65","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.ccell.2024.06.009","article-title":"Spatiotemporal single-cell analysis decodes cellular dynamics underlying different responses to immunotherapy in colorectal cancer","volume":"42","author":"Chen","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2025.101326_bib66","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.drup.2025.101326_bib67","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.addr.2016.01.022","article-title":"The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery","volume":"99","author":"Cheng","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.drup.2025.101326_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.xgen.2025.100893","article-title":"SpaLinker identifies phenotype-associated spatial tumor microenvironment features by integrating bulk and spatial sequencing data","author":"Cheng","year":"2025","journal-title":"Cell Genom."},{"key":"10.1016\/j.drup.2025.101326_bib69","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41377-025-01757-6","article-title":"Photon-triggered pyroptosis and ferroptosis dual-functional nanoplatform for cancer immunotherapy","volume":"14","author":"Cheng","year":"2025","journal-title":"Light Sci. Appl."},{"key":"10.1016\/j.drup.2025.101326_bib70","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1021\/cr400532z","article-title":"Functional nanomaterials for phototherapies of cancer","volume":"114","author":"Cheng","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.drup.2025.101326_bib71","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.120638","article-title":"A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer","volume":"3","author":"Cheng","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.drup.2025.101326_bib72","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.3390\/cancers15215209","article-title":"Harnessing ferroptosis to overcome drug resistance in colorectal cancer: promising therapeutic approaches","volume":"15","author":"Cheng","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.drup.2025.101326_bib73","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1126\/science.abb4255","article-title":"Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic","volume":"369","author":"Chin","year":"2020","journal-title":"Science (80. )"},{"key":"10.1016\/j.drup.2025.101326_bib74","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1039\/D3TB02766J","article-title":"Lipid nanoparticles as the drug carrier for targeted therapy of hepatic disorders","volume":"12","author":"Chu","year":"2024","journal-title":"J. Mater. Chem. B."},{"key":"10.1016\/j.drup.2025.101326_bib75","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.3390\/biomedicines12071624","article-title":"Preclinical models of hepatocellular carcinoma: current utility, limitations, and challenges","volume":"12","author":"Cigliano","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.drup.2025.101326_bib76","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1136\/gutjnl-2022-327909","article-title":"Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade","volume":"72","author":"Conche","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.drup.2025.101326_bib77","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.4049\/jimmunol.1300097","article-title":"Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5, 6-dimethylxanthenone-4-acetic acid","volume":"190","author":"Conlon","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.drup.2025.101326_bib78","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nrd.2015.6","article-title":"Regulated necrosis: disease relevance and therapeutic opportunities","volume":"15","author":"Conrad","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.drup.2025.101326_bib79","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/s41589-019-0408-1","article-title":"The chemical basis of ferroptosis","volume":"15","author":"Conrad","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.drup.2025.101326_bib80","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","article-title":"Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity","volume":"11","author":"Corrales","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.drup.2025.101326_bib81","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.4049\/jimmunol.1502538","article-title":"Antagonism of the STING pathway via activation of the AIM2 inflammasome by intracellular DNA","volume":"196","author":"Corrales","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.drup.2025.101326_bib82","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/jama.2018.10136","article-title":"Real-world evidence and real-world data for evaluating drug safety and effectiveness","volume":"320","author":"Corrigan-Curay","year":"2018","journal-title":"Jama"},{"key":"10.1016\/j.drup.2025.101326_bib83","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/02656736.2014.992484","article-title":"Treating cancer with sonodynamic therapy: a review","volume":"31","author":"Costley","year":"2015","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.drup.2025.101326_bib84","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1089\/ars.2023.0237","article-title":"LPCAT3 is transcriptionally regulated by YAP\/ZEB\/EP300 and collaborates with ACSL4 and YAP to determine ferroptosis sensitivity","volume":"39","author":"Cui","year":"2023","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.drup.2025.101326_bib85","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","article-title":"Lipid nanoparticle systems for enabling gene therapies","volume":"25","author":"Cullis","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.drup.2025.101326_bib86","article-title":"Will Prince Charles et al diminish the opportunities of developing countries in nanotechnology?","author":"Daar","year":"2004","journal-title":"Nanotechweb. Org."},{"key":"10.1016\/j.drup.2025.101326_bib87","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ng1002-229","article-title":"Top ten biotechnologies for improving health in developing countries","volume":"32","author":"Daar","year":"2002","journal-title":"Nat. Genet"},{"key":"10.1016\/j.drup.2025.101326_bib88","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1038\/s41556-024-01360-8","article-title":"A guideline on the molecular ecosystem regulating ferroptosis","volume":"26","author":"Dai","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.drup.2025.101326_bib89","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1080\/15548627.2020.1714209","article-title":"Autophagy-dependent ferroptosis drives tumor-associated macrophage polarization via release and uptake of oncogenic KRAS protein","volume":"16","author":"Dai","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.drup.2025.101326_bib90","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41563-022-01251-z","article-title":"STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity","volume":"21","author":"Dane","year":"2022","journal-title":"Nat. Mater."},{"key":"10.1016\/j.drup.2025.101326_bib91","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drup.2025.101326_bib92","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s12035-023-03646-8","article-title":"Oxytosis\/ferroptosis in neurodegeneration: the underlying role of master regulator glutathione peroxidase 4 (GPX4)","volume":"61","author":"Dar","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.drup.2025.101326_bib93","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41582-020-0362-2","article-title":"Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities","volume":"16","author":"Davis","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.drup.2025.101326_bib94","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd2614","article-title":"Nanoparticle therapeutics: an emerging treatment modality for cancer","volume":"7","author":"Davis","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.drup.2025.101326_bib95","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI67313","article-title":"Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice","volume":"124","author":"Deng","year":"2014","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.drup.2025.101326_bib96","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.immuni.2014.10.019","article-title":"STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors","volume":"41","author":"Deng","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.drup.2025.101326_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120710","article-title":"Low-intensity focused ultrasound-augmented Cascade chemodynamic therapy via boosting ROS generation","volume":"271","author":"Deng","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.drup.2025.101326_bib98","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12951-024-02297-8","article-title":"The application of nanoparticles-based ferroptosis, pyroptosis and autophagy in cancer immunotherapy","volume":"22","author":"Deng","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.drup.2025.101326_bib99","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1208\/s12248-012-9339-4","article-title":"Challenges in development of nanoparticle-based therapeutics","volume":"14","author":"Desai","year":"2012","journal-title":"AAPS J."},{"key":"10.1016\/j.drup.2025.101326_bib100","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202502315","article-title":"Nanoparticle therapeutics in clinical perspective: classification, marketed products, and regulatory landscape","author":"Desai","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.drup.2025.101326_bib101","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202502183","article-title":"Advances in stimuli responsive release strategies for sonosensitizers in synergistic sonodynamic immunotherapy against tumors","author":"Ding","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.drup.2025.101326_bib102","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.drup.2025.101326_bib103","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","article-title":"The cell biology of ferroptosis","volume":"25","author":"Dixon","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.drup.2025.101326_bib104","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.02523","article-title":"Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis","volume":"3","author":"Dixon","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.drup.2025.101326_bib105","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nnano.2007.223","article-title":"Immunological properties of engineered nanomaterials","volume":"2","author":"Dobrovolskaia","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.drup.2025.101326_bib106","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.nano.2008.08.001","article-title":"Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles","volume":"5","author":"Dobrovolskaia","year":"2009","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.drup.2025.101326_bib107","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","article-title":"FSP1 is a glutathione-independent ferroptosis suppressor","volume":"575","author":"Doll","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.drup.2025.101326_bib108","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13059-021-02286-2","article-title":"Giotto: a toolbox for integrative analysis and visualization of spatial expression data","volume":"22","author":"Dries","year":"2021","journal-title":"Genome Biol."},{"key":"10.1016\/j.drup.2025.101326_bib109","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41420-022-01297-7","article-title":"Recent progress in ferroptosis: inducers and inhibitors","volume":"8","author":"Du","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.drup.2025.101326_bib110","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/1061186X.2021.1999963","article-title":"Recent advances in hepatocellular carcinoma therapeutic strategies and imaging-guided treatment","volume":"30","author":"Du","year":"2022","journal-title":"J. Drug Target"},{"key":"10.1016\/j.drup.2025.101326_bib111","doi-asserted-by":"crossref","first-page":"427","DOI":"10.5582\/bst.2023.01275","article-title":"The immune response of hepatocellular carcinoma after locoregional and systemic therapies: the available combination option for immunotherapy","volume":"17","author":"Duan","year":"2023","journal-title":"Biosci. Trends"},{"key":"10.1016\/j.drup.2025.101326_bib112","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/2051013613501988","article-title":"Rationale, progress and development of vaccines utilizing STING-activating cyclic dinucleotide adjuvants","volume":"1","author":"Dubensky","year":"2013","journal-title":"Ther. Adv. Vaccin."},{"key":"10.1016\/j.drup.2025.101326_bib113","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001369","article-title":"Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity","volume":"8","author":"Efimova","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.drup.2025.101326_bib114","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2217\/nnm.13.68","article-title":"Next-generation nanomedicines and nanosimilars: EU regulators-initiatives relating to the development and evaluation of nanomedicines","volume":"8","author":"Ehmann","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.drup.2025.101326_bib115","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nrd3501","article-title":"Bridging the efficacy-effectiveness gap: a regulator\u2019s perspective on addressing variability of drug response","volume":"10","author":"Eichler","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.drup.2025.101326_bib116","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/S0140-6736(17)31046-2","article-title":"J. rg Trojan, T.H. Welling, Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1\/2 dose escalation and expansion trial","volume":"389","author":"El-Khoueiry","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.drup.2025.101326_bib117","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s12032-024-02330-8","article-title":"Probiotic-derived silver nanoparticles target mTOR\/MMP-9\/BCL-2\/dependent AMPK activation for hepatic cancer treatment","volume":"41","author":"Elmetwalli","year":"2024","journal-title":"Med. Oncol."},{"key":"10.1016\/j.drup.2025.101326_bib118","article-title":"Citrate-capped AuNPs-induced redox reprogramming modulates the TP53-BAX\/BCL2-CASP3 Axis, reinforcing antioxidant defense and promoting apoptotic signaling in liver Cancer","author":"Elmetwalli","year":"2025","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.drup.2025.101326_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2025.126630","article-title":"Citrate-capped AuNPs-induced redox reprogramming modulates the TP53\u2013BAX\/BCL2\u2013CASP3 Axis, reinforcing antioxidant defense and promoting apoptotic signaling in liver Cancer","volume":"344","author":"Elmetwalli","year":"2026","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.drup.2025.101326_bib120","doi-asserted-by":"crossref","first-page":"7087","DOI":"10.1007\/s00210-024-03682-8","article-title":"Gold nanoparticles mediate suppression of angiogenesis and breast cancer growth via MMP-9\/NF-\u03baB\/mTOR and PD-L1\/PD-1 signaling: integrative in vitro validation and network pharmacology insights","volume":"398","author":"Elmetwalli","year":"2025","journal-title":"Naunyn. Schmiede Arch. Pharm."},{"key":"10.1016\/j.drup.2025.101326_bib121","first-page":"1","article-title":"Modulation of the oxidative damage, inflammation, and apoptosis-related genes by dicinnamoyl-L-tartaric acid in liver cancer","author":"Elmetwalli","year":"2023","journal-title":"Naunyn. Schmiede Arch. Pharm."},{"key":"10.1016\/j.drup.2025.101326_bib122","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s12032-023-02236-x","article-title":"Novel phloretin-based combinations targeting glucose metabolism in hepatocellular carcinoma through GLUT2\/PEPCK axis of action: in silico molecular modelling and in vivo studies","volume":"41","author":"Elmetwalli","year":"2023","journal-title":"Med. Oncol."},{"key":"10.1016\/j.drup.2025.101326_bib123","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s12032-023-02250-z","article-title":"Ammonia scavenger and glutamine synthetase inhibitors cocktail in targeting mTOR\/\u03b2-catenin and MMP-14 for nitrogen homeostasis and liver cancer","volume":"41","author":"Elmetwalli","year":"2023","journal-title":"Med. Oncol."},{"key":"10.1016\/j.drup.2025.101326_bib124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-023-04142-1","article-title":"Hepatocellular Carcinoma cells: activity of Amygdalin and Sorafenib in Targeting AMPK\/mTOR and BCL-2 for anti-angiogenesis and apoptosis cell death","volume":"23","author":"El-Sewedy","year":"2023","journal-title":"BMC Complement. Med. Ther."},{"key":"10.1016\/j.drup.2025.101326_bib125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-023-03872-6","article-title":"Thymoquinone, piperine, and sorafenib combinations attenuate liver and breast cancers progression: epigenetic and molecular docking approaches","volume":"23","author":"El-Shehawy","year":"2023","journal-title":"BMC Complement. Med. Ther."},{"key":"10.1016\/j.drup.2025.101326_bib126","doi-asserted-by":"crossref","first-page":"1226044","DOI":"10.3389\/fcell.2023.1226044","article-title":"ROS induced lipid peroxidation and their role in ferroptosis","volume":"11","author":"Endale","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.drup.2025.101326_bib127","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cbpa.2009.10.022","article-title":"NIR dyes for bioimaging applications","volume":"14","author":"Escobedo","year":"2010","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.drup.2025.101326_bib128","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.drup.2025.101326_bib129","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/cac2.12414","article-title":"Cancer-associated fibroblast-derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib","volume":"43","author":"Eun","year":"2023","journal-title":"Cancer Commun."},{"key":"10.1016\/j.drup.2025.101326_bib130","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3390\/pharmaceutics17070886","article-title":"ROS-responsive nanoplatforms for targeted tumor immunomodulation: a paradigm shift in precision cancer immunotherapy","volume":"17","author":"Fan","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.drup.2025.101326_bib131","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.actbio.2024.07.034","article-title":"Multifunctional single-component photosensitizers as metal-free ferroptosis inducers for enhanced photodynamic immunotherapy","volume":"186","author":"Fang","year":"2024","journal-title":"Acta Biomater."},{"key":"10.1016\/j.drup.2025.101326_bib132","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1111\/j.1572-0241.2001.04052.x","article-title":"Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis","volume":"96","author":"Fargion","year":"2001","journal-title":"Off. J. Am. Coll. Gastroenterol."},{"key":"10.1016\/j.drup.2025.101326_bib133","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1208\/s12249-025-03133-4","article-title":"Mitigating shear stress in spray drying for RNA-loaded lipid nanoparticles through process and formulation optimization","volume":"26","author":"Farinha","year":"2025","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.drup.2025.101326_bib134","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1021\/nn900002m","article-title":"Impact of nanotechnology on drug delivery","volume":"3","author":"Farokhzad","year":"2009","journal-title":"ACS Nano"},{"key":"10.1016\/j.drup.2025.101326_bib135","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science (80. )"},{"key":"10.1016\/j.drup.2025.101326_bib136","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.febslet.2013.10.002","article-title":"Glypican-3 antibodies: a new therapeutic target for liver cancer","volume":"588","author":"Feng","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.drup.2025.101326_bib137","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41401-020-0439-x","article-title":"ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma","volume":"42","author":"Feng","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.drup.2025.101326_bib138","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2006203","article-title":"Unsolved mysteries: how does lipid peroxidation cause ferroptosis?","volume":"16","author":"Feng","year":"2018","journal-title":"PLoS Biol."},{"key":"10.1016\/j.drup.2025.101326_bib139","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nrm2531","article-title":"Fluorescent probes for super-resolution imaging in living cells","volume":"9","author":"Fern ndez-Su rez","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.drup.2025.101326_bib140","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2025.101326_bib141","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41576-019-0166-7","article-title":"Next-generation computational tools for interrogating cancer immunity","volume":"20","author":"Finotello","year":"2019","journal-title":"Nat. Rev. Genet"},{"key":"10.1016\/j.drup.2025.101326_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121778","article-title":"An audit of pharmaceutical continuous manufacturing regulatory submissions and outcomes in the US","volume":"622","author":"Fisher","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drup.2025.101326_bib143","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3390\/toxins8100274","article-title":"Glypican-3 targeting immunotoxins for the treatment of liver cancer","volume":"8","author":"Fleming","year":"2016","journal-title":"Toxins"},{"key":"10.1016\/j.drup.2025.101326_bib144","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1158\/2326-6066.CIR-16-0284","article-title":"A STING agonist given with OX40 receptor and PD-L1 modulators primes immunity and reduces tumor growth in tolerized mice","volume":"5","author":"Foote","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.drup.2025.101326_bib145","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jnci\/djs629","article-title":"Combining radiotherapy and cancer immunotherapy: a paradigm shift","volume":"105","author":"Formenti","year":"2013","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.drup.2025.101326_bib146","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"carcinoma Bruix JHepatocellular","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.drup.2025.101326_bib147","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/jnci\/djp477","article-title":"Randomized clinical trials with biomarkers: design issues","volume":"102","author":"Freidlin","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.drup.2025.101326_bib148","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","article-title":"Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion","volume":"19","author":"Friedmann Angeli","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2025.101326_bib149","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/ncb3064","article-title":"Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice","volume":"16","author":"Friedmann Angeli","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.drup.2025.101326_bib150","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13234","article-title":"Type I interferons and related pathways in cell senescence","volume":"19","author":"Frisch","year":"2020","journal-title":"Aging Cell"},{"key":"10.1016\/j.drup.2025.101326_bib151","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41419-020-03221-2","article-title":"Detection of immunogenic cell death and its relevance for cancer therapy","volume":"11","author":"Fucikova","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drup.2025.101326_bib152","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1158\/2326-6066.CIR-15-0110","article-title":"Intratumoral CD3 and CD8 T-cell densities associated with relapse-free survival in HCC","volume":"4","author":"Gabrielson","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.drup.2025.101326_bib153","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S1470-2045(21)00151-0","article-title":"Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial","volume":"22","author":"Galle","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.drup.2025.101326_bib154","first-page":"34","article-title":"IMbrave150: updated overall survival (OS) data from a global, randomized, open-label Phase III study of atezolizumab (atezo) plus bevacizumab (bev) vs sorafenib (sor) in patients (pts) with unresectable hepatocellular carcinoma (HCC)","volume":"44","author":"Galle","year":"2021","journal-title":"Oncol. Res. Treat."},{"key":"10.1016\/j.drup.2025.101326_bib155","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","author":"Galle","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.drup.2025.101326_bib156","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000337","article-title":"Consensus guidelines for the definition, detection and interpretation of immunogenic cell death","volume":"8","author":"Galluzzi","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.drup.2025.101326_bib157","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nri3863","article-title":"Iron homeostasis in host defence and inflammation","volume":"15","author":"Ganz","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.drup.2025.101326_bib158","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.cell.2013.07.023","article-title":"Structure-function analysis of STING activation by c [G (2, 5) pA (3, 5) p] and targeting by antiviral DMXAA","volume":"154","author":"Gao","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.drup.2025.101326_bib159","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1021\/mp100253e","article-title":"pH-responsive nanoparticles for drug delivery","volume":"7","author":"Gao","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.drup.2025.101326_bib160","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.1158\/1078-0432.CCR-14-1170","article-title":"Development of T cells redirected to glypican-3 for the treatment of hepatocellular carcinoma","volume":"20","author":"Gao","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2025.101326_bib161","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.biomaterials.2015.07.035","article-title":"CXCR4-targeted lipid-coated PLGA nanoparticles deliver sorafenib and overcome acquired drug resistance in liver cancer","volume":"67","author":"Gao","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.drup.2025.101326_bib162","doi-asserted-by":"crossref","first-page":"1592837","DOI":"10.3389\/fimmu.2025.1592837","article-title":"Metabolic reprogramming in hepatocellular carcinoma: mechanisms of immune evasion and therapeutic implications","volume":"16","author":"Gao","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.drup.2025.101326_bib163","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/cr.2016.95","article-title":"Ferroptosis is an autophagic cell death process","volume":"26","author":"Gao","year":"2016","journal-title":"Cell Res"},{"key":"10.1016\/j.drup.2025.101326_bib164","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/ni.3509","article-title":"Mitochondrial respiratory-chain adaptations in macrophages contribute to antibacterial host defense","volume":"17","author":"Garaude","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.drup.2025.101326_bib165","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jval.2017.12.006","article-title":"An overview of value, perspective, and decision context-a health economics approach: an ISPOR Special Task Force report [2","volume":"21","author":"Garrison","year":"2018","journal-title":"Value Heal"},{"key":"10.1016\/j.drup.2025.101326_bib166","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.bbrc.2016.10.086","article-title":"Lipid peroxidation in cell death","volume":"482","author":"Gaschler","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.drup.2025.101326_bib167","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3390\/vaccines8030453","article-title":"The age of cyclic dinucleotide vaccine adjuvants","volume":"8","author":"Gogoi","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.drup.2025.101326_bib168","doi-asserted-by":"crossref","first-page":"2002178","DOI":"10.1002\/advs.202002178","article-title":"Design and challenges of sonodynamic therapy system for cancer theranostics: from equipment to sensitizers","volume":"8","author":"Gong","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.drup.2025.101326_bib169","doi-asserted-by":"crossref","first-page":"2501095","DOI":"10.1002\/advs.202501095","article-title":"From multi-omics to visualization and beyond: bridging micro and macro insights in CAR-T Cell Therapy","volume":"12","author":"Gong","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.drup.2025.101326_bib170","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3390\/ndt2030017","article-title":"Towards non-destructive quality testing of complex biomedical devices-a generalized closed-loop system approach utilizing real-time in-line process analytical technology","volume":"2","author":"Guha","year":"2024","journal-title":"NDT"},{"key":"10.1016\/j.drup.2025.101326_bib171","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/ng.2256","article-title":"Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma","volume":"44","author":"Guichard","year":"2012","journal-title":"Nat. Genet"},{"key":"10.1016\/j.drup.2025.101326_bib172","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1089\/blr.2011.9814","article-title":"Guidance for industry considering whether an FDA-regulated product involves the application of nanotechnology","volume":"30","author":"Guidance","year":"2011","journal-title":"Biotechnol. Law Rep."},{"key":"10.1016\/j.drup.2025.101326_bib173","unstructured":"Guideline, I.C.H.H.T., 2005. Quality Risk Management, Q9, Curr. Step. 4 (2005) 408."},{"key":"10.1016\/j.drup.2025.101326_bib174","unstructured":"Guideline, I.C.H.H.T., 2008. Pharmaceutical Quality System q10, Curr. Step. 4 (2008).."},{"key":"10.1016\/j.drup.2025.101326_bib175","unstructured":"Guideline, I.C.H.H., 2021. Continuous Manufacturing of Drug Substances and Drug Products Q13."},{"key":"10.1016\/j.drup.2025.101326_bib176","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41580-024-00768-2","article-title":"Profiling cell identity and tissue architecture with single-cell and spatial transcriptomics","volume":"26","author":"Gulati","year":"2025","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.drup.2025.101326_bib177","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12943-020-01297-0","article-title":"Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma","volume":"20","author":"Guo","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2025.101326_bib178","doi-asserted-by":"crossref","first-page":"2400595","DOI":"10.1002\/advs.202400595","article-title":"Revolutionary point of care wearable diagnostics for early disease detection and biomarker discovery through intelligent technologies","volume":"11","author":"Haghayegh","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.drup.2025.101326_bib179","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jconrel.2021.06.016","article-title":"Methodological needs in the quality and safety characterisation of nanotechnology-based health products: priorities for method development and standardisation","volume":"336","author":"Halamoda-Kenzaoui","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drup.2025.101326_bib180","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2217\/17435889.2.6.789","article-title":"Characterization of nanoparticles for therapeutics","volume":"2","author":"Hall","year":"2007","journal-title":"Nanomedicine"},{"key":"10.1016\/j.drup.2025.101326_bib181","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1515\/cclm-2022-1206","article-title":"Principles of ideal diagnostic regulation and the IVDR","volume":"61","author":"Hallersten","year":"2023","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.drup.2025.101326_bib182","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1056\/NEJMp1006304","article-title":"The path to personalized medicine","volume":"363","author":"Hamburg","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2025.101326_bib183","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.drup.2025.101326_bib184","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature24297","article-title":"Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition","volume":"551","author":"Hangauer","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.drup.2025.101326_bib185","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1172\/JCI79915","article-title":"Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants","volume":"125","author":"Hanson","year":"2015","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.drup.2025.101326_bib186","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature23470","article-title":"Mitotic progression following DNA damage enables pattern recognition within micronuclei","volume":"548","author":"Harding","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.drup.2025.101326_bib187","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.addr.2016.04.025","article-title":"Challenges and strategies in anti-cancer nanomedicine development: an industry perspective","volume":"108","author":"Hare","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.drup.2025.101326_bib188","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100197","article-title":"Multiplex immunohistochemistry and immunofluorescence: a practical update for pathologists","volume":"36","author":"Harms","year":"2023","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.drup.2025.101326_bib189","doi-asserted-by":"crossref","first-page":"viii712","DOI":"10.1093\/annonc\/mdy424.015","article-title":"Preliminary results of the first-in-human (FIH) study of MK-1454, an agonist of stimulator of interferon genes (STING), as monotherapy or in combination with pembrolizumab (pembro) in patients with advanced solid tumors or lymphomas","volume":"29","author":"Harrington","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.drup.2025.101326_bib190","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1158\/1078-0432.CCR-10-0196","article-title":"Phase I\/II study of oncolytic HSVGM-CSF in combination with radiotherapy and cisplatin in untreated stage III\/IV squamous cell cancer of the head and neck","volume":"16","author":"Harrington","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2025.101326_bib191","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1126\/science.1111138","article-title":"Small things and big changes in the developing world","volume":"309","author":"Hassan","year":"2005","journal-title":"Science (80. )"},{"key":"10.1016\/j.drup.2025.101326_bib192","doi-asserted-by":"crossref","first-page":"15527","DOI":"10.1074\/jbc.R700054200","article-title":"Oxidized phospholipids as endogenous pattern recognition ligands in innate immunity","volume":"283","author":"Hazen","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2025.101326_bib193","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1016\/j.biomaterials.2011.06.066","article-title":"A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance","volume":"32","author":"He","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.drup.2025.101326_bib194","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.drup.2025.101326_bib195","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.gastro.2013.01.002","article-title":"Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma","volume":"144","author":"Hernandez-Gea","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drup.2025.101326_bib196","doi-asserted-by":"crossref","first-page":"8675","DOI":"10.1245\/s10434-023-14053-7","article-title":"Transferrin receptor is associated with sensitivity to ferroptosis inducers in hepatocellular carcinoma","volume":"30","author":"Hiromatsu","year":"2023","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.drup.2025.101326_bib197","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrclinonc.2010.227","article-title":"Predictive, personalized, preventive, participatory (P4) cancer medicine","volume":"8","author":"Hood","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101326_bib198","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","article-title":"Molecular mechanisms and cellular functions of cGAS-STING signalling","volume":"21","author":"Hopfner","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.drup.2025.101326_bib199","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nmat2608","article-title":"Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging","volume":"9","author":"Horcajada","year":"2010","journal-title":"Nat. Mater."},{"key":"10.1016\/j.drup.2025.101326_bib200","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1158\/0008-5472.CAN-09-1089","article-title":"Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma","volume":"69","author":"Hoshida","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.drup.2025.101326_bib201","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra064142","article-title":"Control of neglected tropical diseases","volume":"357","author":"Hotez","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2025.101326_bib202","doi-asserted-by":"crossref","first-page":"21526","DOI":"10.18632\/oncotarget.15630","article-title":"CD163 as a marker of M2 macrophage, contribute to predict aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma","volume":"8","author":"Hu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2025.101326_bib203","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12974-022-02602-y","article-title":"Emerging role of STING signalling in CNS injury: inflammation, autophagy, necroptosis, ferroptosis and pyroptosis","volume":"19","author":"Hu","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.drup.2025.101326_bib204","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3389\/fphar.2018.00790","article-title":"Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: pathways for translational development and commercialization","volume":"9","author":"Hua","year":"2018","journal-title":"Front. Pharm."},{"key":"10.1016\/j.drup.2025.101326_bib205","doi-asserted-by":"crossref","first-page":"1399926","DOI":"10.3389\/fimmu.2024.1399926","article-title":"Enhancing immunotherapy outcomes by targeted remodeling of the tumor microenvironment via combined cGAS-STING pathway strategies","volume":"15","author":"Huang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.drup.2025.101326_bib206","doi-asserted-by":"crossref","first-page":"11092","DOI":"10.3390\/ijms231911092","article-title":"SHP-1\/STAT3-signaling-axis-regulated coupling between BECN1 and SLC7A11 contributes to sorafenib-induced ferroptosis in hepatocellular carcinoma","volume":"23","author":"Huang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.drup.2025.101326_bib207","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.32604\/or.2025.066805","article-title":"Igniting cold tumors: multi-omics-driven strategies to overcome immune evasion and restore immune surveillance","volume":"33","author":"Huang","year":"2025","journal-title":"Oncol. Res."},{"key":"10.1016\/j.drup.2025.101326_bib208","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1021\/jacs.6b11846","article-title":"Metalloporphyrin-encapsulated biodegradable nanosystems for highly efficient magnetic resonance imaging-guided sonodynamic cancer therapy","volume":"139","author":"Huang","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.drup.2025.101326_bib209","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/s41467-025-56344-5","article-title":"Palmitoylation-dependent regulation of GPX4 suppresses ferroptosis","volume":"16","author":"Huang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101326_bib210","unstructured":"I.C.H. ICH, Q8 (R2) Pharmaceutical Development, ICH Q9 (Quality Risk Manag. ICH Q. 10 (2009)."},{"key":"10.1016\/j.drup.2025.101326_bib211","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/cas.12368","article-title":"Japanese phase I study of GC 33, a humanized antibody against glypican 3 for advanced hepatocellular carcinoma","volume":"105","author":"Ikeda","year":"2014","journal-title":"Cancer Sci."},{"key":"10.1016\/j.drup.2025.101326_bib212","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/097172180701300105","article-title":"Nanotechnology\u2019s controversial role for the South","volume":"13","author":"Invernizzi","year":"2008","journal-title":"Sci. Technol. Soc."},{"key":"10.1016\/j.drup.2025.101326_bib213","doi-asserted-by":"crossref","first-page":"9832","DOI":"10.1158\/0008-5472.CAN-08-1973","article-title":"Anti-glypican 3 antibody as a potential antitumor agent for human liver cancer","volume":"68","author":"Ishiguro","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.drup.2025.101326_bib214","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature07317","article-title":"STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling","volume":"455","author":"Ishikawa","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.drup.2025.101326_bib215","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2147\/OTT.S404035","article-title":"Remarkable clinical response of ALK-rearranged\/TP53-mutant lung adenocarcinoma with liver metastasis to Atezolizumab-Bevacizumab-Carboplatin-paclitaxel after ALK inhibitors: a case report","author":"Iso","year":"2023","journal-title":"Onco-Targets Ther."},{"key":"10.1016\/j.drup.2025.101326_bib216","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/nrclinonc.2016.36","article-title":"Driving CAR T-cells forward","volume":"13","author":"Jackson","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101326_bib217","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0140-6736(17)32906-9","article-title":"Universal health coverage and intersectoral action for health: key messages from Disease Control Priorities","volume":"391","author":"Jamison","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.drup.2025.101326_bib218","doi-asserted-by":"crossref","first-page":"8353","DOI":"10.1038\/s41467-023-43458-x","article-title":"High resolution mapping of the tumor microenvironment using integrated single-cell, spatial and in situ analysis","volume":"14","author":"Janesick","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101326_bib219","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.addr.2010.08.004","article-title":"Imaging and drug delivery using theranostic nanoparticles","volume":"62","author":"Janib","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.drup.2025.101326_bib220","doi-asserted-by":"crossref","first-page":"8529","DOI":"10.1002\/anie.201203263","article-title":"Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo","volume":"51","author":"Jayaraman","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.drup.2025.101326_bib221","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1172\/JCI79100","article-title":"Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations","volume":"124","author":"Jeremiah","year":"2014","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.drup.2025.101326_bib222","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3390\/pharmaceutics15020638","article-title":"Liposomal delivery of MIW815 (ADU-S100) for potentiated STING activation","volume":"15","author":"Ji","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.drup.2025.101326_bib223","doi-asserted-by":"crossref","first-page":"2103868","DOI":"10.1002\/smll.202103868","article-title":"Chemodynamic therapy via fenton and fenton like nanomaterials: strategies and recent advances","volume":"18","author":"Jia","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.drup.2025.101326_bib224","first-page":"1","article-title":"Spatial immune scoring system predicts hepatocellular carcinoma recurrence","author":"Jia","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.drup.2025.101326_bib225","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3389\/fimmu.2016.00690","article-title":"Anti-GPC3-CAR T cells suppress the growth of tumor cells in patient-derived xenografts of hepatocellular carcinoma","volume":"7","author":"Jiang","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.drup.2025.101326_bib226","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature14344","article-title":"Ferroptosis as a p53-mediated activity during tumour suppression","volume":"520","author":"Jiang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.drup.2025.101326_bib227","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.drup.2025.101326_bib228","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41420-024-01863-1","article-title":"Ferroptosis: a new hunter of hepatocellular carcinoma","volume":"10","author":"Jiang","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.drup.2025.101326_bib229","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1038\/s41401-024-01336-2","article-title":"The regulation and function of Nrf2 signaling in ferroptosis-activated cancer therapy","volume":"45","author":"Jiang","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.drup.2025.101326_bib230","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.freeradbiomed.2023.08.025","article-title":"STING promotes ferroptosis through NCOA4-dependent ferritinophagy in acute kidney injury","volume":"208","author":"Jin","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.drup.2025.101326_bib231","series-title":"Companion Complement. Diagnostics","first-page":"307","article-title":"Regulatory Requirements for Companion Diagnostics and Drug-Diagnostic Codevelopment in the United States","author":"Jorgensen","year":"2019"},{"key":"10.1016\/j.drup.2025.101326_bib232","first-page":"OF1","article-title":"Mitochondrial HSP90 paralog TRAP1 deletion drives glutamine addiction in tumor cells via destablization of the Cys\/Glu antiporter SLC7A11\/xCT","author":"Joshi","year":"2025","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.drup.2025.101326_bib233","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.aar6711","article-title":"CAR T cell immunotherapy for human cancer","volume":"359","author":"June","year":"2018","journal-title":"Science (80. )"},{"key":"10.1016\/j.drup.2025.101326_bib234","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/ijms20020273","article-title":"Iron as a central player and promising target in cancer progression","volume":"20","author":"Jung","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.drup.2025.101326_bib235","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1039\/c2cs15344k","article-title":"Targeted polymeric therapeutic nanoparticles: design, development and clinical translation","volume":"41","author":"Kamaly","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.drup.2025.101326_bib236","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj7002","article-title":"Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity","volume":"8","author":"Kamerkar","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.drup.2025.101326_bib237","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.omtm.2023.08.008","article-title":"Necessity of strengthening the current clinical regulatory for companion diagnostics: an institutional comparison of the FDA, EMA, and MFDS","volume":"30","author":"Kang","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.drup.2025.101326_bib238","doi-asserted-by":"crossref","DOI":"10.1159\/000547334","article-title":"Challenges and opportunities in the application of CRISPR-Cas9: a review on genomic editing and therapeutic potentials","author":"Karimi","year":"2025","journal-title":"Med. Princ. Pr."},{"key":"10.1016\/j.drup.2025.101326_bib239","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.ultrasmedbio.2008.10.013","article-title":"Sonoporation by ultrasound-activated microbubble contrast agents: effect of acoustic exposure parameters on cell membrane permeability and cell viability","volume":"35","author":"Karshafian","year":"2009","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.drup.2025.101326_bib240","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1021\/bc200151q","article-title":"Theranostics: combining imaging and therapy","volume":"22","author":"Kelkar","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.drup.2025.101326_bib241","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000343856","article-title":"Hepatic iron overload and hepatocellular carcinoma","volume":"3","author":"Kew","year":"2014","journal-title":"Liver Cancer"},{"key":"10.1016\/j.drup.2025.101326_bib242","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nnano.2016.164","article-title":"Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growth","volume":"11","author":"Kim","year":"2016","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.drup.2025.101326_bib243","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/bjc.2013.408","article-title":"A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer","volume":"109","author":"Ko","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.drup.2025.101326_bib244","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/JLB.3MA1220-815RRR","article-title":"IFN\u03b3-mediated repression of system xc\u2212 drives vulnerability to induced ferroptosis in hepatocellular carcinoma cells","volume":"110","author":"Kong","year":"2021","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.drup.2025.101326_bib245","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.cell.2013.09.049","article-title":"Cyclic dinucleotides trigger ULK1 (ATG1) phosphorylation of STING to prevent sustained innate immune signaling","volume":"155","author":"Konno","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.drup.2025.101326_bib246","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/s41388-017-0120-0","article-title":"Suppression of STING signaling through epigenetic silencing and missense mutation impedes DNA damage mediated cytokine production","volume":"37","author":"Konno","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2025.101326_bib247","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1038\/s41467-022-29905-1","article-title":"A targetable CoQ-FSP1 axis drives ferroptosis-and radiation-resistance in KEAP1 inactive lung cancers","volume":"13","author":"Koppula","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101326_bib248","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1007\/s12029-021-00759-y","article-title":"Role of biobanks for cancer research and precision medicine in hepatocellular carcinoma","volume":"52","author":"Korhan","year":"2021","journal-title":"J. Gastrointest. Cancer"},{"key":"10.1016\/j.drup.2025.101326_bib249","doi-asserted-by":"crossref","first-page":"1600013","DOI":"10.1002\/adbi.201600013","article-title":"Liposomal delivery enhances immune activation by STING agonists for cancer immunotherapy","volume":"1","author":"Koshy","year":"2017","journal-title":"Adv. Biosyst."},{"key":"10.1016\/j.drup.2025.101326_bib250","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","article-title":"GTP cyclohydrolase 1\/tetrahydrobiopterin counteract ferroptosis through lipid remodeling","volume":"6","author":"Kraft","year":"2019","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.drup.2025.101326_bib251","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.drup.2025.101326_bib252","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2025.101326_bib253","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.drup.2025.101326_bib254","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s12032-009-9203-2","article-title":"Altered iron metabolism, inflammation, transferrin receptors, and ferritin expression in non-small-cell lung cancer","volume":"27","author":"Kukulj","year":"2010","journal-title":"Med. Oncol."},{"key":"10.1016\/j.drup.2025.101326_bib255","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.mri.2012.06.010","article-title":"Radiomics: the process and the challenges","volume":"30","author":"Kumar","year":"2012","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.drup.2025.101326_bib256","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/hep.29904","article-title":"Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification","volume":"68","author":"Kurebayashi","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.drup.2025.101326_bib257","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/2159-8290.CD-19-0761","article-title":"The cytosolic DNA-sensing cGAS-STING pathway in cancer","volume":"10","author":"Kwon","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.drup.2025.101326_bib258","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1021\/ar200019c","article-title":"Theranostic nanomedicine","volume":"44","author":"Lammers","year":"2011","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.drup.2025.101326_bib259","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/sj.bjc.6604483","article-title":"Tumour-targeted nanomedicines: principles and practice","volume":"99","author":"Lammers","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.drup.2025.101326_bib260","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41592-020-01038-7","article-title":"Spatially resolved transcriptomics adds a new dimension to genomics","volume":"18","author":"Larsson","year":"2021","journal-title":"Nat. Methods"},{"key":"10.1016\/j.drup.2025.101326_bib261","first-page":"607","article-title":"Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schema","volume":"34","author":"Lassere","year":"2007","journal-title":"J. Rheuma"},{"key":"10.1016\/j.drup.2025.101326_bib262","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1126\/science.aab3291","article-title":"DNA tumor virus oncogenes antagonize the cGAS-STING DNA-sensing pathway","volume":"350","author":"Lau","year":"2015","journal-title":"Science (80. )"},{"key":"10.1016\/j.drup.2025.101326_bib263","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.biomaterials.2018.01.035","article-title":"STINGel: controlled release of a cyclic dinucleotide for enhanced cancer immunotherapy","volume":"163","author":"Leach","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.drup.2025.101326_bib264","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jconrel.2008.05.003","article-title":"Recent progress in tumor pH targeting nanotechnology","volume":"132","author":"Lee","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drup.2025.101326_bib265","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1038\/s41467-025-60457-2","article-title":"Precision targeting of -catenin induces tumor reprogramming and immunity in hepatocellular cancers","volume":"16","author":"Lehrich","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101326_bib266","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41422-019-0263-3","article-title":"The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression","volume":"30","author":"Lei","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.drup.2025.101326_bib267","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2022.212761","article-title":"Anti-tumor immunity and ferroptosis of hepatocellular carcinoma are enhanced by combined therapy of sorafenib and delivering modified GO-based PD-L1 siRNAs","volume":"136","author":"Li","year":"2022","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.drup.2025.101326_bib268","doi-asserted-by":"crossref","first-page":"19049","DOI":"10.1038\/srep19049","article-title":"Antitumor activity of cGAMP via stimulation of cGAS-cGAMP-STING-IRF3 mediated innate immune response","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drup.2025.101326_bib269","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1039\/D4TB01227E","article-title":"Endocytosis: the match point of nanoparticle-based cancer therapy","volume":"12","author":"Li","year":"2024","journal-title":"J. Mater. Chem. B."},{"key":"10.1016\/j.drup.2025.101326_bib270","first-page":"1","article-title":"Reciprocal regulation between ferroptosis and STING-type I interferon pathway suppresses head and neck squamous cell carcinoma growth through dendritic cell maturation","author":"Li","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2025.101326_bib271","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102535","article-title":"Spatiotemporal orchestration of a ferroptosis-immunotherapy \u201ccycle\u201d via a sequential drug delivery system for antitumor immunity","volume":"59","author":"Li","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.drup.2025.101326_bib272","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jconrel.2016.01.044","article-title":"Restoring anti-tumor functions of T cells via nanoparticle-mediated immune checkpoint modulation","volume":"231","author":"Li","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drup.2025.101326_bib273","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg3049","article-title":"Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer","volume":"15","author":"Li","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.drup.2025.101326_bib274","article-title":"System Xc\u2212\/GSH\/GPX4 axis: an important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharm."},{"key":"10.1016\/j.drup.2025.101326_bib275","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/hep.30646","article-title":"A frizzled like cysteine rich domain in glypican 3 mediates wnt binding and regulates hepatocellular carcinoma tumor growth in mice","volume":"70","author":"Li","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.drup.2025.101326_bib276","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.7150\/jca.66978","article-title":"Highly potent immunotoxins targeting the membrane-distal N-lobe of GPC3 for immunotherapy of hepatocellular carcinoma","volume":"13","author":"Li","year":"2022","journal-title":"J. Cancer"},{"key":"10.1016\/j.drup.2025.101326_bib277","doi-asserted-by":"crossref","first-page":"23711","DOI":"10.1021\/acsnano.4c08463","article-title":"Biodegradable Long-Circulating nanoagonists optimize Tumor-Tropism Chemo-Metalloimmunotherapy for boosted antitumor immunity by cascade cGAS-STING pathway activation","volume":"18","author":"Li","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.drup.2025.101326_bib278","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s13046-025-03520-6","article-title":"Targeting the interplay of cGAS-STING and ferroptosis by nanomedicine in the treatment of cancer","volume":"44","author":"Li","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.drup.2025.101326_bib279","doi-asserted-by":"crossref","first-page":"1643235","DOI":"10.3389\/fonc.2025.1643235","article-title":"Ferroptosis\u2019s Master Switch GPX4 emerges as universal biomarker for precision immunotherapy: a pan-cancer study with in vitro experiments validation","volume":"15","author":"Li","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.drup.2025.101326_bib280","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1021\/acs.nanolett.9b01595","article-title":"Intelligent hollow Pt-CuS janus architecture for synergistic catalysis-enhanced sonodynamic and photothermal cancer therapy","volume":"19","author":"Liang","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.drup.2025.101326_bib281","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.scib.2023.02.027","article-title":"Specific activation of cGAS-STING pathway by nanotherapeutics-mediated ferroptosis evoked endogenous signaling for boosting systemic tumor immunotherapy","volume":"68","author":"Liang","year":"2023","journal-title":"Sci. Bull."},{"key":"10.1016\/j.drup.2025.101326_bib282","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114022","article-title":"Manganese oxide nanoparticle acts as a promising immune adjuvant via tuning ferroptosis signaling","author":"Liang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drup.2025.101326_bib283","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tibtech.2020.05.006","article-title":"Uncovering an organ\u2019s molecular architecture at single-cell resolution by spatially resolved transcriptomics","volume":"39","author":"Liao","year":"2021","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.drup.2025.101326_bib284","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1751-7915.2011.00306.x","article-title":"Cyclic di nucleotides: new era for small molecules as adjuvants","volume":"5","author":"Libanova","year":"2012","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.drup.2025.101326_bib285","first-page":"587","article-title":"Nanomaterials for theranostics: recent advances and future challenges","author":"Lim","year":"2021","journal-title":"Nanomater. Neoplasms"},{"key":"10.1016\/j.drup.2025.101326_bib286","doi-asserted-by":"crossref","first-page":"10253","DOI":"10.1021\/acs.jmedchem.6b01300","article-title":"Design, synthesis, and biological evaluation of novel cyclic adenosine\u2013inosine monophosphate (cAIMP) analogs that activate stimulator of interferon genes (STING)","volume":"59","author":"Lioux","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drup.2025.101326_bib287","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1021\/ar300150c","article-title":"Nanoparticulate X-ray computed tomography contrast agents: from design validation to in vivo applications","volume":"45","author":"Liu","year":"2012","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.drup.2025.101326_bib288","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaa2630","article-title":"Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation","volume":"347","author":"Liu","year":"2015","journal-title":"Science (80. )"},{"key":"10.1016\/j.drup.2025.101326_bib289","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.nantod.2018.06.008","article-title":"Nanomedicine for tumor microenvironment modulation and cancer treatment enhancement","volume":"21","author":"Liu","year":"2018","journal-title":"Nano Today"},{"key":"10.1016\/j.drup.2025.101326_bib290","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1038\/s41467-019-13094-5","article-title":"An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases","volume":"10","author":"Liu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101326_bib291","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000246","article-title":"Sorafenib induces ferroptosis by promoting TRIM54-mediated FSP1 ubiquitination and degradation in hepatocellular carcinoma","volume":"7","author":"Liu","year":"2023","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.drup.2025.101326_bib292","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.tips.2024.05.006","article-title":"Targeting GPX4 in ferroptosis and cancer: chemical strategies and challenges","volume":"45","author":"Liu","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.drup.2025.101326_bib293","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ultsonch.2016.01.038","article-title":"Sinoporphyrin sodium triggered sono-photodynamic effects on breast cancer both in vitro and in vivo","volume":"31","author":"Liu","year":"2016","journal-title":"Ultrason. Sonochem."},{"key":"10.1016\/j.drup.2025.101326_bib294","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.cell.2020.10.026","article-title":"High-spatial-resolution multi-omics sequencing via deterministic barcoding in tissue","volume":"183","author":"Liu","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.drup.2025.101326_bib295","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113107","article-title":"MCM4 potentiates evasion of hepatocellular carcinoma from sorafenib-induced ferroptosis through Nrf2 signaling pathway","volume":"142","author":"Liu","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.drup.2025.101326_bib296","first-page":"1","article-title":"NF- B signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.drup.2025.101326_bib297","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101326_bib298","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41572-024-00500-6","article-title":"Author correction: hepatocellular carcinoma","volume":"10","author":"Llovet","year":"2024","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.drup.2025.101326_bib299","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s43018-022-00357-2","article-title":"Molecular pathogenesis and systemic therapies for hepatocellular carcinoma","volume":"3","author":"Llovet","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.drup.2025.101326_bib300","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.drup.2025.101326_bib301","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2025.101326_bib302","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"Lo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.drup.2025.101326_bib303","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41576-021-00370-8","article-title":"Integrating single-cell and spatial transcriptomics to elucidate intercellular tissue dynamics","volume":"22","author":"Longo","year":"2021","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.drup.2025.101326_bib304","unstructured":"R. Lopez, A. Nazaret, M. Langevin, J. Samaran, J. Regier, M.I. Jordan, N. Yosef, A joint model of unpaired data from scRNA-seq and spatial transcriptomics for imputing missing gene expression measurements, ArXiv Prepr. ArXiv1905.02269. (2019)."},{"key":"10.1016\/j.drup.2025.101326_bib305","doi-asserted-by":"crossref","first-page":"2307051","DOI":"10.1002\/adma.202307051","article-title":"Microfluidic Platforms for Real Time In Situ Monitoring of Biomarkers for Cellular Processes","volume":"36","author":"Lou","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.drup.2025.101326_bib306","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/ijc.28159","article-title":"Iron dependent cell death of hepatocellular carcinoma cells exposed to sorafenib","volume":"133","author":"Louandre","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.drup.2025.101326_bib307","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13046-021-02208-x","article-title":"Epigenetic regulation of ferroptosis via ETS1\/miR-23a-3p\/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma","volume":"41","author":"Lu","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.drup.2025.101326_bib308","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nmeth.2892","article-title":"Single-cell in situ RNA profiling by sequential hybridization","volume":"11","author":"Lubeck","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.drup.2025.101326_bib309","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.4049\/jimmunol.174.12.7516","article-title":"Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor","volume":"174","author":"Lugade","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.drup.2025.101326_bib310","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1021\/cr200358s","article-title":"X-ray-computed tomography contrast agents","volume":"113","author":"Lusic","year":"2013","journal-title":"Chem. Rev."},{"key":"10.1016\/j.drup.2025.101326_bib311","doi-asserted-by":"crossref","first-page":"202","DOI":"10.15252\/embr.201439366","article-title":"Positive feedback regulation of type I interferon by the interferon stimulated gene STING","volume":"16","author":"Ma","year":"2015","journal-title":"EMBO Rep."},{"key":"10.1016\/j.drup.2025.101326_bib312","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116234","article-title":"Disrupting mitochondrial dynamics attenuates ferroptosis and chemotoxicity via upregulating NRF2-mediated FSP1 expression","volume":"44","author":"Ma","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.drup.2025.101326_bib313","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114305","article-title":"Hepatocyte-targeted lipid nanoparticle for full-length ATP7B mRNA delivery in Wilson disease","author":"Ma","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drup.2025.101326_bib314","doi-asserted-by":"crossref","first-page":"831","DOI":"10.15252\/embj.201593339","article-title":"Ribonuclease H2 mutations induce a cGAS\/STING dependent innate immune response","volume":"35","author":"Mackenzie","year":"2016","journal-title":"EMBO J."},{"key":"10.1016\/j.drup.2025.101326_bib315","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature23449","article-title":"cGAS surveillance of micronuclei links genome instability to innate immunity","volume":"548","author":"Mackenzie","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.drup.2025.101326_bib316","article-title":"Nanotechnology and developing countries","author":"Maclurcan","year":"2006","journal-title":"Sci. Focus"},{"key":"10.1016\/j.drup.2025.101326_bib317","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.chembiol.2018.11.016","article-title":"Exogenous monounsaturated fatty acids promote a ferroptosis-resistant cell state","volume":"26","author":"Magtanong","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.drup.2025.101326_bib318","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12951-022-01309-9","article-title":"Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances","volume":"20","author":"Mahmoud","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.drup.2025.101326_bib319","first-page":"225","article-title":"Nanotechnology: Regulatory outlook on nanomaterials and nanomedicines in United States, Europe and India","volume":"7","author":"Malik","year":"2020","journal-title":"Appl. Clin. Res. Clin. Trials Regul. Aff."},{"key":"10.1016\/j.drup.2025.101326_bib320","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature13148","article-title":"Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy","volume":"509","author":"Mancias","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.drup.2025.101326_bib321","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/nyas.13008","article-title":"Iron and cancer: recent insights","volume":"1368","author":"Manz","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.drup.2025.101326_bib322","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, S taging, and M anagement of H epatocellular C arcinoma: 2018 P ractice G uidance by the A merican A ssociation for the S tudy of L iver D iseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.drup.2025.101326_bib323","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","article-title":"Cancer metabolism: looking forward","volume":"21","author":"Mart nez-Reyes","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2025.101326_bib324","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41592-020-01033-y","article-title":"Method of the Year: spatially resolved transcriptomics","volume":"18","author":"Marx","year":"2021","journal-title":"Nat. Methods"},{"key":"10.1016\/j.drup.2025.101326_bib325","unstructured":"Mason, R.P., Zhao, D., Pacheco-Torres, J.S., Cui, W., Kodibagkar, V.D., Gulaka, P.K., Hao, G., Thorpe, P., Hahn, E.W., Peschke, P., 2010. Multimodality imaging of hypoxia in preclinical settings. Q. J. Nucl. Med. Mol. Imaging Off. Publ. Ital. Assoc. Nucl. Med. (AIMN) Int. Assoc. Radiopharmacol. (IAR), Sect. Soc. Of.54259.."},{"key":"10.1016\/j.drup.2025.101326_bib326","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1158\/1535-7163.MCT-06-0118","article-title":"Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice","volume":"5","author":"Mayer","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drup.2025.101326_bib327","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1124\/mi.7.4.8","article-title":"Optimizing combination chemotherapy by controlling drug ratios","volume":"7","author":"Mayer","year":"2007","journal-title":"Mol. Interv."},{"key":"10.1016\/j.drup.2025.101326_bib328","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2025.101326_bib329","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/978-3-319-22536-4_22","article-title":"Sonodynamic therapy: concept, mechanism and application to cancer treatment","author":"McHale","year":"2016","journal-title":"Ther. Ultrasound"},{"key":"10.1016\/j.drup.2025.101326_bib330","doi-asserted-by":"crossref","unstructured":"Meric-Bernstam, F., Sandhu, S.K., Hamid, O., Spreafico, A., Kasper, S., Dummer, R., Shimizu, T., Steeghs, N., Lewis, N., Talluto, C.C., 2019. Phase Ib study of MIW815 (ADU-S100) in combination with spartalizumab (PDR001) in patients (pts) with advanced\/metastatic solid tumors or lymphomas..","DOI":"10.1200\/JCO.2019.37.15_suppl.2507"},{"key":"10.1016\/j.drup.2025.101326_bib331","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1078-0432.CCR-21-1963","article-title":"Phase I dose-escalation trial of MIW815 (ADU-S100), an intratumoral STING agonist, in patients with advanced\/metastatic solid tumors or lymphomas","volume":"28","author":"Meric-Bernstam","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2025.101326_bib332","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1158\/1078-0432.CCR-22-2235","article-title":"Combination of the STING agonist MIW815 (ADU-S100) and PD-1 inhibitor spartalizumab in advanced\/metastatic solid tumors or lymphomas: an open-label, multicenter, phase Ib study","volume":"29","author":"Meric-Bernstam","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2025.101326_bib333","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s13346-020-00740-5","article-title":"Challenges in nanomedicine clinical translation","volume":"10","author":"Metselaar","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.drup.2025.101326_bib334","article-title":"Nanostructures and nanoparticles as medical diagnostic imaging contrast agents: a review","volume":"40","author":"Mhlanga","year":"2024","journal-title":"Mater. Today Chem."},{"key":"10.1016\/j.drup.2025.101326_bib335","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/10715769609145652","article-title":"EPR spin trapping study of the decomposition of azo compounds in aqueous solutions by ultrasound: potential for use as sonodynamic sensitizers for cell killing","volume":"25","author":"Mi k","year":"1996","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.drup.2025.101326_bib336","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s10198-023-01639-x","article-title":"Special FDA designations for drug development: orphan, fast track, accelerated approval, priority review, and breakthrough therapy","volume":"25","author":"Michaeli","year":"2024","journal-title":"Eur. J. Heal. Econ."},{"key":"10.1016\/j.drup.2025.101326_bib337","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.drup.2025.101326_bib338","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jconrel.2014.04.004","article-title":"A new adjuvant delivery system \u2018cyclic di-GMP\/YSK05 liposome\u2019 for cancer immunotherapy","volume":"184","author":"Miyabe","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drup.2025.101326_bib339","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau5324","article-title":"Molecular, spatial, and functional single-cell profiling of the hypothalamic preoptic region","volume":"362","author":"Moffitt","year":"2018","journal-title":"Science (80. )"},{"key":"10.1016\/j.drup.2025.101326_bib340","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1201\/9780429399039-7","article-title":"Biomolecular coronas provide the biological identity of nanosized materials","author":"Monopoli","year":"2020","journal-title":"Nano-Enabled Med. Appl."},{"key":"10.1016\/j.drup.2025.101326_bib341","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s43018-021-00236-2","article-title":"An artificial intelligence framework integrating longitudinal electronic health records with real-world data enables continuous pan-cancer prognostication","volume":"2","author":"Morin","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.drup.2025.101326_bib342","article-title":"Advances in the treatment of hepatocellular carcinoma: an overview of the current and evolving therapeutic landscape for clinicians","author":"Moris","year":"2025","journal-title":"Ca. Cancer J. Clin."},{"key":"10.1016\/j.drup.2025.101326_bib343","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s41592-022-01409-2","article-title":"Museum of spatial transcriptomics","volume":"19","author":"Moses","year":"2022","journal-title":"Nat. Methods"},{"key":"10.1016\/j.drup.2025.101326_bib344","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41576-019-0151-1","article-title":"DNA sensing by the cGAS-STING pathway in health and disease","volume":"20","author":"Motwani","year":"2019","journal-title":"Nat. Rev. Genet"},{"key":"10.1016\/j.drup.2025.101326_bib345","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","article-title":"Ferroptosis, a new form of cell death: opportunities and challenges in cancer","volume":"12","author":"Mou","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.drup.2025.101326_bib346","doi-asserted-by":"crossref","DOI":"10.1159\/000545639","article-title":"Neutrophil percentage-to-Albumin Ratio as a predictor of acute Kidney Injury in cirrhotic patients: a novel approach utilizing artificial intelligence","author":"Mousa","year":"2025","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.drup.2025.101326_bib347","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12645-023-00234-2","article-title":"Enhanced cancer immunotherapy through synergistic ferroptosis and immune checkpoint blockade using cell membrane-coated nanoparticles","volume":"14","author":"Mu","year":"2023","journal-title":"Cancer Nanotechnol."},{"key":"10.1016\/j.drup.2025.101326_bib348","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2013.66","article-title":"Influence of polyethylene glycol lipid desorption rates on pharmacokinetics and pharmacodynamics of siRNA lipid nanoparticles","volume":"2","author":"Mui","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.drup.2025.101326_bib349","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nmat3776","article-title":"Stimuli-responsive nanocarriers for drug delivery","volume":"12","author":"Mura","year":"2013","journal-title":"Nat. Mater."},{"key":"10.1016\/j.drup.2025.101326_bib350","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1002\/adma.200802366","article-title":"Inorganic nanoparticles for MRI contrast agents","volume":"21","author":"Na","year":"2009","journal-title":"Adv. Mater."},{"key":"10.1016\/j.drup.2025.101326_bib351","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/ni.1980","article-title":"Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome","volume":"12","author":"Nakahira","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.drup.2025.101326_bib352","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2015.08.026","article-title":"Liposomes loaded with a STING pathway ligand, cyclic di-GMP, enhance cancer immunotherapy against metastatic melanoma","volume":"216","author":"Nakamura","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drup.2025.101326_bib353","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/hep.31175","article-title":"Biomarkers for hepatobiliary cancers","volume":"73","author":"Nault","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.drup.2025.101326_bib354","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.1114397","article-title":"Toxic potential of materials at the nanolevel","volume":"311","author":"Nel","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.drup.2025.101326_bib355","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1056\/NEJMp1405158","article-title":"Updating cost-effectiveness-the curious resilience of the $50,000-per-QALY threshold","volume":"371","author":"Neumann","year":"2014","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.drup.2025.101326_bib356","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2020.100909","article-title":"The role of oxidized phospholipids in the development of disease","volume":"76","author":"Nie","year":"2020","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.drup.2025.101326_bib357","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","article-title":"EMT: 2016","volume":"166","author":"Nieto","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.drup.2025.101326_bib358","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.bioeng.8.061505.095831","article-title":"Fluorescence molecular imaging","volume":"8","author":"Ntziachristos","year":"2006","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.drup.2025.101326_bib359","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1289\/ehp.7339","article-title":"Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles","volume":"113","author":"Oberd rster","year":"2005","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.drup.2025.101326_bib360","article-title":"Biomarker and companion diagnostics-a review of medicinal products approved by the European Medicines Agency","volume":"8","author":"Orellana Garc a","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.drup.2025.101326_bib361","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/hep.22626","article-title":"A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma","volume":"49","author":"Palmer","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.drup.2025.101326_bib362","doi-asserted-by":"crossref","first-page":"20875","DOI":"10.1021\/acsnano.3c07763","article-title":"Nanomedicine strategies in conquering and utilizing the cancer hypoxia environment","volume":"17","author":"Pan","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.drup.2025.101326_bib363","doi-asserted-by":"crossref","first-page":"13659","DOI":"10.1002\/ange.202004894","article-title":"MOF derived double layer hollow nanoparticles with oxygen generation ability for multimodal imaging guided sonodynamic therapy","volume":"132","author":"Pan","year":"2020","journal-title":"Angew. Chem."},{"key":"10.1016\/j.drup.2025.101326_bib364","doi-asserted-by":"crossref","first-page":"7442","DOI":"10.1021\/nn404501g","article-title":"Facing the truth about nanotechnology in drug delivery","volume":"7","author":"Park","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.drup.2025.101326_bib365","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw199","article-title":"Activation of STING-dependent innate immune signaling by S-phase-specific DNA damage in breast cancer","volume":"109","author":"Parkes","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"issue":"December 11, 2024","key":"10.1016\/j.drup.2025.101326_bib366","article-title":"Artificial intelligence-driven predictive maintenance in manufacturing: enhancing operational efficiency, minimizing downtime, and optimizing resource utilization, Minimizing Downtime","author":"Patil","year":"2024","journal-title":"Optim. Resour. Util."},{"key":"10.1016\/j.drup.2025.101326_bib367","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1201\/9780429399039-2","article-title":"Nanocarriers as an emerging platform for cancer therapy","author":"Peer","year":"2020","journal-title":"Nano-Enabled Med. Appl."},{"key":"10.1016\/j.drup.2025.101326_bib368","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105088","article-title":"Emerging role of ferroptosis in metabolic dysfunction-associated steatotic liver disease: revisiting hepatic lipid peroxidation","volume":"102","author":"Peleman","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.drup.2025.101326_bib369","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nchembio798","article-title":"Combinatorial chemistry identifies high-affinity peptidomimetics against 4 1 integrin for in vivo tumor imaging","volume":"2","author":"Peng","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.drup.2025.101326_bib370","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1038\/s41467-020-18570-x","article-title":"PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade","volume":"11","author":"Peng","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101326_bib371","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.15252\/embr.201439246","article-title":"The extracellular matrix modulates the hallmarks of cancer","volume":"15","author":"Pickup","year":"2014","journal-title":"EMBO Rep."},{"key":"10.1016\/j.drup.2025.101326_bib372","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/gutjnl-2025-334928","article-title":"Systemic treatment in patients with hepatocellular carcinoma and advanced liver dysfunction","volume":"74","author":"Pinter","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.drup.2025.101326_bib373","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nrgastro.2015.173","article-title":"Immunological landscape and immunotherapy of hepatocellular carcinoma","volume":"12","author":"Prieto","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.drup.2025.101326_bib374","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.2174\/0113816128339788241221160639","article-title":"Activation of the cGAS-sting Pathway Mediated by Nanocomplexes for Tumor Therapy","volume":"31","author":"Qian","year":"2025","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.drup.2025.101326_bib375","doi-asserted-by":"crossref","first-page":"8097","DOI":"10.1002\/adma.201602012","article-title":"Micro\/nanoparticle augmented sonodynamic therapy (SDT): breaking the depth shallow of photoactivation","volume":"28","author":"Qian","year":"2016","journal-title":"Adv. Mater."},{"key":"10.1016\/j.drup.2025.101326_bib376","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41422-023-00788-1","article-title":"Mitochondria-localized cGAS suppresses ferroptosis to promote cancer progression","volume":"33","author":"Qiu","year":"2023","journal-title":"Cell Res"},{"key":"10.1016\/j.drup.2025.101326_bib377","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105491","article-title":"Potential therapeutic strategies for colitis and colon cancer: bidirectional targeting STING pathway","volume":"111","author":"Qu","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.drup.2025.101326_bib378","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41586-018-0705-y","article-title":"Design of amidobenzimidazole STING receptor agonists with systemic activity","volume":"564","author":"Ramanjulu","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.drup.2025.101326_bib379","series-title":"in: Semin. Liver Dis.","first-page":"433","article-title":"Hepatotoxicity of iron overload: mechanisms of iron-induced hepatic fibrogenesis","author":"Ramm","year":"2005"},{"key":"10.1016\/j.drup.2025.101326_bib380","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-019-2692-6","article-title":"Quality-by-Design Concepts to Improve Nanotechnology-Based Drug Development","volume":"36","author":"Rawal","year":"2019","journal-title":"Pharm. Res."},{"key":"10.1016\/j.drup.2025.101326_bib381","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.221856","article-title":"Quantification of liver iron overload with MRI: review and guidelines from the ESGAR and SAR","volume":"307","author":"Reeder","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.drup.2025.101326_bib382","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.drup.2025.101326_bib383","doi-asserted-by":"crossref","first-page":"vi365","DOI":"10.1093\/annonc\/mdw378.21","article-title":"Phase 1b\/2, open-label, multicenter, dose escalation and expansion trial of intratumoral SD 101 in combination with pembrolizumab in patients with metastatic melanoma","volume":"27","author":"Ribas","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.drup.2025.101326_bib384","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0891-5849(92)90021-8","article-title":"Free radical formation induced by ultrasound and its biological implications","volume":"13","author":"Riesz","year":"1992","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.drup.2025.101326_bib385","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nbt1235","article-title":"Protein biomarker discovery and validation: the long and uncertain path to clinical utility","volume":"24","author":"Rifai","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.drup.2025.101326_bib386","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1021\/acs.biochem.0c00226","article-title":"cGAMP as an adjuvant in antiviral vaccines and cancer immunotherapy","volume":"59","author":"Ritchie","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.drup.2025.101326_bib387","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3390\/ijms24010449","article-title":"Lipid peroxidation and iron metabolism: two corner stones in the homeostasis control of ferroptosis","volume":"24","author":"Rochette","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.drup.2025.101326_bib388","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s11051-005-3141-5","article-title":"International perspective on government nanotechnology funding in 2005","volume":"7","author":"Roco","year":"2005","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.drup.2025.101326_bib389","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1126\/science.aaw1219","article-title":"Slide-seq: a scalable technology for measuring genome-wide expression at high spatial resolution","volume":"363","author":"Rodriques","year":"2019","journal-title":"Science (80. )"},{"key":"10.1016\/j.drup.2025.101326_bib390","doi-asserted-by":"crossref","first-page":"602","DOI":"10.7150\/thno.48353","article-title":"Cytosolic Ca2+ transients during pulsed focused ultrasound generate reactive oxygen species and cause DNA damage in tumor cells","volume":"11","author":"Rosenblatt","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.drup.2025.101326_bib391","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ultsonch.2004.03.004","article-title":"Sonodynamic therapy--a review of the synergistic effects of drugs and ultrasound","volume":"11","author":"Rosenthal","year":"2004","journal-title":"Ultrason. Sonochem."},{"key":"10.1016\/j.drup.2025.101326_bib392","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/s43018-022-00468-w","article-title":"The cGAS-STING pathway and cancer","volume":"3","author":"Samson","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.drup.2025.101326_bib393","doi-asserted-by":"crossref","first-page":"6330","DOI":"10.1039\/D3NR06131K","article-title":"Nanomedicine as a multimodal therapeutic paradigm against cancer: on the way forward in advancing precision therapy","volume":"16","author":"Sandbhor","year":"2024","journal-title":"Nanoscale"},{"key":"10.1016\/j.drup.2025.101326_bib394","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41575-021-00438-0","article-title":"Advances in immunotherapy for hepatocellular carcinoma","volume":"18","author":"Sangro","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.drup.2025.101326_bib395","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3390\/ph18030325","article-title":"Therapeutic approaches with iron oxide nanoparticles to induce ferroptosis and overcome radioresistance in cancers","volume":"18","author":"Sant\u2019Angelo","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.drup.2025.101326_bib396","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3390\/pr9030457","article-title":"Emerging challenges and opportunities in pharmaceutical manufacturing and distribution","volume":"9","author":"Sarkis","year":"2021","journal-title":"Processes"},{"key":"10.1016\/j.drup.2025.101326_bib397","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1158\/1078-0432.CCR-11-3044","article-title":"Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival","volume":"18","author":"Sawada","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2025.101326_bib398","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ng.3252","article-title":"Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets","volume":"47","author":"Schulze","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.drup.2025.101326_bib399","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nbt.1602","article-title":"Rational design of cationic lipids for siRNA delivery","volume":"28","author":"Semple","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.drup.2025.101326_bib400","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1158\/2159-8290.CD-18-1020","article-title":"Targeting DNA damage response promotes antitumor immunity through STING-mediated T-cell activation in small cell lung cancer","volume":"9","author":"Sen","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.drup.2025.101326_bib401","doi-asserted-by":"crossref","first-page":"10240","DOI":"10.3390\/ijms262010240","article-title":"Reactive Oxygen Species Across Death Pathways: Gatekeepers of Apoptosis, Ferroptosis, Pyroptosis, Paraptosis, and Beyond","volume":"26","author":"Sendtner","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.drup.2025.101326_bib402","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1016\/S1470-2045(17)30074-8","article-title":"iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics","volume":"18","author":"Seymour","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.drup.2025.101326_bib403","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41565-018-0342-5","article-title":"Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy","volume":"14","author":"Shae","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.drup.2025.101326_bib404","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.drup.2025.101326_bib405","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1093\/ajcp\/aqz121.018","article-title":"Hematological parameters throughout the first month of direct-acting antivirus (DAA) plus Ribavirin for HCV","volume":"152","author":"Shedid","year":"2019","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.drup.2025.101326_bib406","doi-asserted-by":"crossref","first-page":"1704007","DOI":"10.1002\/adma.201704007","article-title":"Emerging strategies of cancer therapy based on ferroptosis","volume":"30","author":"Shen","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.drup.2025.101326_bib407","doi-asserted-by":"crossref","first-page":"9408","DOI":"10.1039\/D5RA00032G","article-title":"A hollow nanozyme-based multifunctional platform enhances sonodynamic-chemodynamic-induced ferroptosis for cancer therapy","volume":"15","author":"Shen","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.drup.2025.101326_bib408","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2025.101326_bib409","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.817643","article-title":"Identification of ferroptosis-related biomarkers for prognosis and immunotherapy in patients with glioma","volume":"10","author":"Shi","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.drup.2025.101326_bib410","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1111\/febs.16034","article-title":"Emerging roles of ferroptosis in the tumor immune landscape: from danger signals to anti tumor immunity","volume":"289","author":"Shi","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.drup.2025.101326_bib411","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1158\/1078-0432.CCR-19-3259","article-title":"Chimeric antigen receptor-glypican-3 T-cell therapy for advanced hepatocellular carcinoma: results of phase I trials","volume":"26","author":"Shi","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2025.101326_bib412","first-page":"1","article-title":"Molecular mechanisms and therapeutic strategies of GPX4 regulation in acute kidney injury","author":"Shi","year":"2025","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.drup.2025.101326_bib413","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S2468-1253(20)30294-6","article-title":"Redefining fatty liver disease: an international patient perspective","volume":"6","author":"Shiha","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.drup.2025.101326_bib414","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nchembio.2079","article-title":"Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis","volume":"12","author":"Shimada","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.drup.2025.101326_bib415","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/j.1349-7006.2009.01206.x","article-title":"Glypican 3 expression is correlated with poor prognosis in hepatocellular carcinoma","volume":"100","author":"Shirakawa","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.drup.2025.101326_bib416","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1053\/j.gastro.2017.06.007","article-title":"Identification of an immune-specific class of hepatocellular carcinoma, based on molecular features","volume":"153","author":"Sia","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drup.2025.101326_bib417","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/j.gastro.2016.11.048","article-title":"Liver cancer cell of origin, molecular class, and effects on patient prognosis","volume":"152","author":"Sia","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drup.2025.101326_bib418","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.3390\/nano10091700","article-title":"Application of nanomaterials in biomedical imaging and cancer therapy","volume":"10","author":"Siddique","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.drup.2025.101326_bib419","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2217\/pme.09.49","article-title":"Clinical trial designs for evaluating the medical utility of prognostic and predictive biomarkers in oncology","volume":"7","author":"Simon","year":"2010","journal-title":"Per. Med."},{"key":"10.1016\/j.drup.2025.101326_bib420","first-page":"39","article-title":"Biomarker based clinical trial design","volume":"3","author":"Simon","year":"2014","journal-title":"Chin. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101326_bib421","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrd3979","article-title":"Implementing personalized cancer genomics in clinical trials","volume":"12","author":"Simon","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.drup.2025.101326_bib422","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrclinonc.2017.14","article-title":"Integrating liquid biopsies into the management of cancer","volume":"14","author":"Siravegna","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101326_bib423","series-title":"in: Nanotechnol. Based Strateg. Cancer Immunother. Concepts, Des. Clin. Appl","first-page":"21","article-title":"Therapeutic Hallmarks of Cancer and Immunology","author":"Sirvi","year":"2025"},{"key":"10.1016\/j.drup.2025.101326_bib424","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001095","article-title":"Safety and clinical activity of intratumoral MEDI9197 alone and in combination with durvalumab and\/or palliative radiation therapy in patients with advanced solid tumors","volume":"8","author":"Siu","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.drup.2025.101326_bib425","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.aac4255","article-title":"Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy","volume":"350","author":"Sivan","year":"2015","journal-title":"Science (80. )"},{"key":"10.1016\/j.drup.2025.101326_bib426","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1016\/j.celrep.2018.11.047","article-title":"Magnitude of therapeutic STING activation determines CD8+ T cell-mediated anti-tumor immunity","volume":"25","author":"Sivick","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.drup.2025.101326_bib427","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/128_2010_68","article-title":"Carbohydrate polymers for nonviral nucleic acid delivery","author":"Sizovs","year":"2010","journal-title":"Nucleic Acid. Transf."},{"key":"10.1016\/j.drup.2025.101326_bib428","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1172\/JCI87624","article-title":"Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors","volume":"127","author":"Smith","year":"2017","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.drup.2025.101326_bib429","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3389\/fchem.2018.00360","article-title":"Nanomedicine: principles, properties, and regulatory issues","volume":"6","author":"Soares","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.drup.2025.101326_bib430","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1039\/C9CS00648F","article-title":"Multifunctional sonosensitizers in sonodynamic cancer therapy","volume":"49","author":"Son","year":"2020","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.drup.2025.101326_bib431","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ccell.2017.04.003","article-title":"Tumor-residing Batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy","volume":"31","author":"Spranger","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2025.101326_bib432","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.aaf2403","article-title":"Visualization and analysis of gene expression in tissue sections by spatial transcriptomics","volume":"353","author":"St hl","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.drup.2025.101326_bib433","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/bcpt.13578","article-title":"Predictive biomarkers and clinical evidence","volume":"128","author":"st J rgensen","year":"2021","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.drup.2025.101326_bib434","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nm.2198","article-title":"Therapeutic cell engineering with surface-conjugated synthetic nanoparticles","volume":"16","author":"Stephan","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.drup.2025.101326_bib435","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.drup.2025.101326_bib436","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.tcb.2020.02.009","article-title":"Emerging mechanisms and disease relevance of ferroptosis","volume":"30","author":"Stockwell","year":"2020","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.drup.2025.101326_bib437","doi-asserted-by":"crossref","first-page":"20240057","DOI":"10.1515\/ntrev-2024-0057","article-title":"Smart bionanomaterials for treatment and diagnosis of inflammatory bowel disease","volume":"13","author":"Stojanov","year":"2024","journal-title":"Nanotechnol. Rev."},{"key":"10.1016\/j.drup.2025.101326_bib438","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.28251","article-title":"Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells","volume":"63","author":"Sun","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.drup.2025.101326_bib439","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.drup.2025.101326_bib440","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ccell.2023.11.010","article-title":"Integrated multi-omics profiling to dissect the spatiotemporal evolution of metastatic hepatocellular carcinoma","volume":"42","author":"Sun","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2025.101326_bib441","article-title":"Immunity Modulating Metal Based Nanomaterials for Cancer Immunotherapy","author":"Sun","year":"2025","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.drup.2025.101326_bib442","first-page":"31","article-title":"Engineered nanoparticles for drug delivery in cancer therapy","author":"Sun","year":"2021","journal-title":"Nanomater. Neoplasms"},{"key":"10.1016\/j.drup.2025.101326_bib443","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA","volume":"71","author":"Sung","year":"2021","journal-title":"Cancer J. Clin."},{"key":"10.1016\/j.drup.2025.101326_bib444","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1158\/0008-5472.CAN-21-3914","article-title":"GLS2 is a tumor suppressor and a regulator of ferroptosis in hepatocellular carcinoma","volume":"82","author":"Suzuki","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2025.101326_bib445","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ultras.2008.02.003","article-title":"Sonodynamic therapy","volume":"48","author":"Tachibana","year":"2008","journal-title":"Ultrasonics"},{"key":"10.1016\/j.drup.2025.101326_bib446","series-title":"Nanoformulation Strateg. Cancer Treat","first-page":"341","article-title":"Good laboratory practice and current good manufacturing practice requirements in the development of cancer nanomedicines","author":"Taleuzzaman","year":"2021"},{"key":"10.1016\/j.drup.2025.101326_bib447","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2023.215316","article-title":"Advanced nanomaterials targeting activation of STING for enhanced cancer immunotherapy","volume":"493","author":"Tan","year":"2023","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.drup.2025.101326_bib448","doi-asserted-by":"crossref","first-page":"ra20","DOI":"10.1126\/scisignal.2002521","article-title":"STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway","volume":"5","author":"Tanaka","year":"2012","journal-title":"Sci. Signal"},{"key":"10.1016\/j.drup.2025.101326_bib449","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res"},{"key":"10.1016\/j.drup.2025.101326_bib450","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","article-title":"The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects","volume":"5","author":"Tang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.drup.2025.101326_bib451","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1208\/s12249-022-02214-y","article-title":"Sorafenib-loaded PLGA-TPGS nanosystems enhance hepatocellular carcinoma therapy through reversing P-glycoprotein-mediated multidrug resistance","volume":"23","author":"Tang","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.drup.2025.101326_bib452","doi-asserted-by":"crossref","first-page":"1862949","DOI":"10.1080\/2162402X.2020.1862949","article-title":"Ferroptosis becomes immunogenic: implications for anticancer treatments","volume":"10","author":"Tang","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.drup.2025.101326_bib453","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1039\/D4CC06501H","article-title":"Engineered extracellular vesicles: an emerging nanomedicine therapeutic platform","volume":"61","author":"Tang","year":"2025","journal-title":"Chem. Commun."},{"key":"10.1016\/j.drup.2025.101326_bib454","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13045-020-00946-7","article-title":"Ferroptosis, necroptosis, and pyroptosis in anticancer immunity","volume":"13","author":"Tang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.drup.2025.101326_bib455","doi-asserted-by":"crossref","DOI":"10.1002\/advs.72596","article-title":"Tumor targeted FABP5\/STING cascade promote radiofrequency ablation induced ferroptosis and intratumoral immune rewiring in hepatocellular carcinoma","author":"Tang","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.drup.2025.101326_bib456","doi-asserted-by":"crossref","first-page":"2203973","DOI":"10.1002\/advs.202203973","article-title":"Targeted xCT-mediated ferroptosis and protumoral polarization of macrophages is effective against HCC and enhances the efficacy of the anti-PD-1\/L1 response","volume":"10","author":"Tang","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.drup.2025.101326_bib457","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.1158\/0008-5472.CAN-19-0369","article-title":"Stearoyl-CoA desaturase 1 protects ovarian cancer cells from ferroptotic cell death","volume":"79","author":"Tesfay","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2025.101326_bib458","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrd4333","article-title":"Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery","volume":"13","author":"Torchilin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.drup.2025.101326_bib459","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc3495","article-title":"Iron and cancer: more ore to be mined","volume":"13","author":"Torti","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2025.101326_bib460","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/SLA.0b013e31828329b8","article-title":"A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL\/AASLD recommendations?: an observational study of the HCC East-West study group","volume":"257","author":"Torzilli","year":"2013","journal-title":"Ann. Surg."},{"key":"10.1016\/j.drup.2025.101326_bib461","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/ng.3126","article-title":"Trans-ancestry mutational landscape of hepatocellular carcinoma genomes","volume":"46","author":"Totoki","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.drup.2025.101326_bib462","first-page":"1","article-title":"Prospects for ferroptosis therapies in cancer","author":"Ubellacker","year":"2025","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.drup.2025.101326_bib463","series-title":"Contrast Agents I Magn. Reson. Imaging","first-page":"61","article-title":"Relaxivity of MRI contrast agents","author":"va","year":"2002"},{"key":"10.1016\/j.drup.2025.101326_bib464","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1201\/9780429399039-3","article-title":"Microfluidic technologies for accelerating the clinical translation of nanoparticles","author":"Valencia","year":"2020","journal-title":"Nano-Enabled Med. Appl."},{"issue":"Jan. 2011","key":"10.1016\/j.drup.2025.101326_bib465","article-title":"General principles and practices","author":"Validation","year":"2011","journal-title":"Guid. Ind."},{"key":"10.1016\/j.drup.2025.101326_bib466","doi-asserted-by":"crossref","first-page":"15618","DOI":"10.1038\/ncomms15618","article-title":"DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity","volume":"8","author":"Vanpouille-Box","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101326_bib467","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41573-019-0043-2","article-title":"Pharmacological modulation of nucleic acid sensors-therapeutic potential and persisting obstacles","volume":"18","author":"Vanpouille-Box","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.drup.2025.101326_bib468","author":"Vasiyani","year":"2023","journal-title":"Study Expression CyclicGMPAMP Synthase (cGAS) Stimulator Interferon Genes (STING) Breast Cancer Potential AntiCancer Therapy"},{"key":"10.1016\/j.drup.2025.101326_bib469","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005344","article-title":"Regulatory implications of ctDNA in immuno-oncology for solid tumors","volume":"11","author":"Vellanki","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.drup.2025.101326_bib470","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jconrel.2021.03.043","article-title":"The dawn of mRNA vaccines: The COVID-19 case","volume":"333","author":"Verbeke","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drup.2025.101326_bib471","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/s41592-019-0548-y","article-title":"High-definition spatial transcriptomics for in situ tissue profiling","volume":"16","author":"Vickovic","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.drup.2025.101326_bib472","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature23007","article-title":"Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway","volume":"547","author":"Viswanathan","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.drup.2025.101326_bib473","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nbt1006-1211","article-title":"The emerging nanomedicine landscape","volume":"24","author":"Wagner","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.drup.2025.101326_bib474","article-title":"Postmarket studies required by the US Food and Drug Administration for new drugs and biologics approved between 2009 and 2012: cross sectional analysis","volume":"361","author":"Wallach","year":"2018","journal-title":"Bmj"},{"key":"10.1016\/j.drup.2025.101326_bib475","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/hep.29117","article-title":"Characterization of ferroptosis in murine models of hemochromatosis","volume":"66","author":"Wang","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.drup.2025.101326_bib476","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41419-021-03718-4","article-title":"GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2\/GPX4 axis","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drup.2025.101326_bib477","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41392-025-02216-9","article-title":"STING aggravates ferroptosis-dependent myocardial ischemia-reperfusion injury by targeting GPX4 for autophagic degradation","volume":"10","author":"Wang","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.drup.2025.101326_bib478","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12951-022-01278-z","article-title":"Tumor microenvironment-responsive fenton nanocatalysts for intensified anticancer treatment","volume":"20","author":"Wang","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.drup.2025.101326_bib479","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.drup.2025.101326_bib480","article-title":"Versatile PLGA Based Drug Delivery Systems for Tumor Immunotherapy","author":"Wang","year":"2025","journal-title":"Small Methods"},{"key":"10.1016\/j.drup.2025.101326_bib481","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41392-023-01720-0","article-title":"Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.drup.2025.101326_bib482","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.actbio.2022.11.007","article-title":"Amplifying STING activation by bioinspired nanomedicine for targeted chemo-and immunotherapy of acute myeloid leukemia","volume":"157","author":"Wang","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.drup.2025.101326_bib483","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41422-023-00791-6","article-title":"cGASing mitochondria to fend off ferroptosis","volume":"33","author":"Wang","year":"2023","journal-title":"Cell Res"},{"key":"10.1016\/j.drup.2025.101326_bib484","doi-asserted-by":"crossref","first-page":"12380","DOI":"10.1021\/acsnano.8b06399","article-title":"Arginine-rich manganese silicate nanobubbles as a ferroptosis-inducing agent for tumor-targeted theranostics","volume":"12","author":"Wang","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.drup.2025.101326_bib485","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1038\/s41467-023-38601-7","article-title":"Gas therapy potentiates aggregation-induced emission luminogen-based photoimmunotherapy of poorly immunogenic tumors through cGAS-STING pathway activation","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101326_bib486","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12943-020-01247-w","article-title":"cGAS-STING pathway in cancer biotherapy","volume":"19","author":"Wang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2025.101326_bib487","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12964-025-02169-0","article-title":"Unveiling the crossroads of STING signaling pathway and metabolic reprogramming: the multifaceted role of the STING in the TME and new prospects in cancer therapies","volume":"23","author":"Wang","year":"2025","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.drup.2025.101326_bib488","article-title":"Crosstalk between ferroptosis and innate immune in diabetic kidney disease: mechanisms and therapeutic implications","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.drup.2025.101326_bib489","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1186\/s12951-024-02808-7","article-title":"Ferroptosis-inducing nanomedicine and targeted short peptide for synergistic treatment of hepatocellular carcinoma","volume":"22","author":"Wang","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.drup.2025.101326_bib490","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00204-023-03476-6","article-title":"ROS-induced lipid peroxidation modulates cell death outcome: mechanisms behind apoptosis, autophagy, and ferroptosis","volume":"97","author":"Wang","year":"2023","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.drup.2025.101326_bib491","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100916","article-title":"Overcoming cancer chemotherapy resistance by the induction of ferroptosis","volume":"66","author":"Wang","year":"2023","journal-title":"Drug Resist. Updat"},{"key":"10.1016\/j.drup.2025.101326_bib492","first-page":"1","article-title":"Interplay of cGAS-STING and ferroptosis: crosstalk, molecular mechanisms, and therapeutic prospects","author":"Wang","year":"2025","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.drup.2025.101326_bib493","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3390\/ph18030334","article-title":"Advances in ferroptosis research: a comprehensive review of mechanism exploration, drug development, and disease treatment","volume":"18","author":"Wang","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.drup.2025.101326_bib494","article-title":"Disruption of MerTK increases the efficacy of checkpoint inhibitor by enhancing ferroptosis and immune response in hepatocellular carcinoma","volume":"5","author":"Wang","year":"2024","journal-title":"Cell Rep. Med"},{"key":"10.1016\/j.drup.2025.101326_bib495","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000282","article-title":"Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma","volume":"8","author":"Wang-Bishop","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.drup.2025.101326_bib496","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40820-025-01862-6","article-title":"SynergistiC Ferroptosis\u2013immunotherapy Nanoplatforms: Multidimensional Engineering for Tumor Microenvironment Remodeling and Therapeutic Optimization","volume":"18","author":"Wei","year":"2026","journal-title":"Nano-Micro Lett."},{"key":"10.1016\/j.drup.2025.101326_bib497","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1056\/NEJMsb0911104","article-title":"Comparative effectiveness and health care spending-implications for reform","volume":"362","author":"Weinstein","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2025.101326_bib498","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/86684","article-title":"A clearer vision for in vivo imaging","volume":"19","author":"Weissleder","year":"2001","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.drup.2025.101326_bib499","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/ajg.2013.160","article-title":"Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States","volume":"108","author":"Welzel","year":"2013","journal-title":"Off. J. Am. Coll. Gastroenterol."},{"key":"10.1016\/j.drup.2025.101326_bib500","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.bbrc.2019.01.090","article-title":"The release and activity of HMGB1 in ferroptosis","volume":"510","author":"Wen","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.drup.2025.101326_bib501","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1038\/s41467-022-31218-2","article-title":"Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity","volume":"13","author":"Wiernicki","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101326_bib502","first-page":"611","article-title":"ICH Q10 Quality Systems","author":"Wigman","year":"2018","journal-title":"ICH Qual. Guide"},{"key":"10.1016\/j.drup.2025.101326_bib503","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13073-022-01075-1","article-title":"An introduction to spatial transcriptomics for biomedical research","volume":"14","author":"Williams","year":"2022","journal-title":"Genome Med."},{"key":"10.1016\/j.drup.2025.101326_bib504","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.nano.2017.10.013","article-title":"Biodegradable STING agonist nanoparticles for enhanced cancer immunotherapy","volume":"14","author":"Wilson","year":"2018","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.drup.2025.101326_bib505","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/nbt1339","article-title":"Mechanisms and optimization of in vivo delivery of lipophilic siRNAs","volume":"25","author":"Wolfrum","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.drup.2025.101326_bib506","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.drup.2025.101326_bib507","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMra1510062","article-title":"Master protocols to study multiple therapies, multiple diseases, or both","volume":"377","author":"Woodcock","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2025.101326_bib508","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.1229963","article-title":"Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA","volume":"339","author":"Wu","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.drup.2025.101326_bib509","doi-asserted-by":"crossref","first-page":"6747","DOI":"10.1158\/0008-5472.CAN-16-1404","article-title":"Recurrent loss of STING signaling in melanoma correlates with susceptibility to viral oncolysis","volume":"76","author":"Xia","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2025.101326_bib510","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.celrep.2015.12.029","article-title":"Deregulation of STING signaling in colorectal carcinoma constrains DNA damage responses and correlates with tumorigenesis","volume":"14","author":"Xia","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.drup.2025.101326_bib511","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.102610","article-title":"The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma","volume":"51","author":"Xia","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.drup.2025.101326_bib512","doi-asserted-by":"crossref","first-page":"23","DOI":"10.7150\/thno.10202","article-title":"Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine","volume":"5","author":"Xiang","year":"2015","journal-title":"Theranostics"},{"key":"10.1016\/j.drup.2025.101326_bib513","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243812","article-title":"Transferrin receptor regulates malignancies and the stemness of hepatocellular carcinoma-derived cancer stem-like cells by affecting iron accumulation","volume":"15","author":"Xiao","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.drup.2025.101326_bib514","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/cdd.2015.158","article-title":"Ferroptosis: process and function","volume":"23","author":"Xie","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.drup.2025.101326_bib515","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.addr.2010.07.009","article-title":"Nanoparticle-based theranostic agents","volume":"62","author":"Xie","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.drup.2025.101326_bib516","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.2147\/JIR.S506964","article-title":"The dual roles of STAT3 in ferroptosis: mechanism, regulation and therapeutic potential","author":"Xie","year":"2025","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.drup.2025.101326_bib517","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.123063","article-title":"Bioactive microspheres to enhance sonodynamic-embolization-metalloimmune therapy for orthotopic liver cancer","volume":"317","author":"Xu","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.drup.2025.101326_bib518","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109235","article-title":"The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity","volume":"35","author":"Xu","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.drup.2025.101326_bib519","doi-asserted-by":"crossref","first-page":"8579","DOI":"10.1021\/acsnano.4c14102","article-title":"Reprogramming the Tolerogenic Immune Response Against Pancreatic Cancer Metastases by Lipid Nanoparticles Delivering a STING Agonist Plus Mutant KRAS mRNA","volume":"19","author":"Xu","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.drup.2025.101326_bib520","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtbio.2025.101848","article-title":"Sorafenib-loaded metal-organic framework nanoparticles for anti-hepatocellular carcinoma effects through synergistically potentiating ferroptosis and remodeling tumor immune microenvironment","author":"Yan","year":"2025","journal-title":"Mater. Today Bio."},{"key":"10.1016\/j.drup.2025.101326_bib521","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41467-024-55785-8","article-title":"S100P is a ferroptosis suppressor to facilitate hepatocellular carcinoma development by rewiring lipid metabolism","volume":"16","author":"Yang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101326_bib522","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.drup.2025.101326_bib523","article-title":"Targeted Nanosensitizer-Augmented Sono-Immunotherapy with STING Agonist to Remodel the Immune Microenvironment in Hepatocellular Carcinoma","author":"Yang","year":"2025","journal-title":"Acta Biomater."},{"key":"10.1016\/j.drup.2025.101326_bib524","article-title":"Temporally programmed STING nanoadjuvant delivery unlocks synergistic chemotherapy-induced antitumor immunity","volume":"11","author":"Yang","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.drup.2025.101326_bib525","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3390\/pharmaceutics17070937","article-title":"Recent Advances in Nanotechnology-Based Approaches for Ferroptosis Therapy and Imaging Diagnosis in Pancreatic Cancer","volume":"17","author":"Yang","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.drup.2025.101326_bib526","doi-asserted-by":"crossref","first-page":"7577","DOI":"10.1021\/acs.nanolett.5c01440","article-title":"Direct cGAMP Delivery via Iron Oxide Nanoparticles for Enhanced STING Activation and Durable Antitumor Immunity","volume":"25","author":"Yang","year":"2025","journal-title":"Nano Lett."},{"key":"10.1016\/j.drup.2025.101326_bib527","first-page":"1","article-title":"Liquid Biopsy in Hepatocellular Carcinoma: ctDNA as a Potential Biomarker for Diagnosis and Prognosis","author":"Yang","year":"2025","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.drup.2025.101326_bib528","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.drup.2025.101326_bib529","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.chembiol.2008.02.010","article-title":"Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells","volume":"15","author":"Yang","year":"2008","journal-title":"Chem. Biol."},{"key":"10.1016\/j.drup.2025.101326_bib530","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112945","article-title":"HIF-1\u03b1 drives resistance to ferroptosis in solid tumors by promoting lactate production and activating SLC1A1","volume":"42","author":"Yang","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.drup.2025.101326_bib531","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1021\/nl100996u","article-title":"Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy","volume":"10","author":"Yang","year":"2010","journal-title":"Nano Lett."},{"key":"10.1016\/j.drup.2025.101326_bib532","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103877","article-title":"Intersection of immune signaling and cell death: The bidirectional regulatory mechanism of STING pathway and Ferroptosis","author":"Yao","year":"2025","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.drup.2025.101326_bib533","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1470-2045(21)00604-5","article-title":"Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial","volume":"23","author":"Yau","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.drup.2025.101326_bib534","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12761","article-title":"Ferroptosis: final destination for cancer?","volume":"53","author":"Ye","year":"2020","journal-title":"Cell Prolif."},{"key":"10.1016\/j.drup.2025.101326_bib535","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41419-024-06584-y","article-title":"Metabolism-regulated ferroptosis in cancer progression and therapy","volume":"15","author":"Ye","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drup.2025.101326_bib536","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.addr.2016.09.001","article-title":"Opportunities for new CT contrast agents to maximize the diagnostic potential of emerging spectral CT technologies","volume":"113","author":"Yeh","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.drup.2025.101326_bib537","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12943-024-02186-6","article-title":"Nanomedicines harnessing cGAS-STING pathway: sparking immune revitalization to transform \u2018cold\u2019 tumors into \u2018hot\u2019 tumors","volume":"23","author":"Ying","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2025.101326_bib538","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.drup.2025.101326_bib539","doi-asserted-by":"crossref","first-page":"6655","DOI":"10.1021\/acsnano.5b01320","article-title":"Clearance pathways and tumor targeting of imaging nanoparticles","volume":"9","author":"Yu","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.drup.2025.101326_bib540","article-title":"Developing Potent Therapeutics for Liver Cancer Chemoresistance via an RNA Nanotech and Series-Circuit-Christmas-Bulb Mechanism Targeting ABC Transporters","author":"Yudhistira","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.drup.2025.101326_bib541","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1349-7006.1989.tb02295.x","article-title":"Hematoporphyrin as a sensitizer of cell damaging effect of ultrasound","volume":"80","author":"Yumita","year":"1989","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.drup.2025.101326_bib542","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13059-022-02653-7","article-title":"Statistical and machine learning methods for spatially resolved transcriptomics data analysis","volume":"23","author":"Zeng","year":"2022","journal-title":"Genome Biol."},{"key":"10.1016\/j.drup.2025.101326_bib543","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12943-025-02366-y","article-title":"Enhancing radiotherapy-induced anti-tumor immunity via nanoparticle-mediated STING agonist synergy","volume":"24","author":"Zeng","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2025.101326_bib544","doi-asserted-by":"crossref","unstructured":"B. Zhai, D. Shi, H. Gao, X. Qi, H. Jiang, Y. Zhang, J. Chi, H. Ruan, H. Wang, Q.C. Ru, A phase I study of anti-GPC3 chimeric antigen receptor modified T cells (GPC3 CAR-T) in Chinese patients with refractory or relapsed GPC3+ hepatocellular carcinoma (r\/r GPC3+ HCC)., (2017).","DOI":"10.1200\/JCO.2017.35.15_suppl.3049"},{"key":"10.1016\/j.drup.2025.101326_bib545","article-title":"Homologous magnetic targeted immune vesicles for amplifying immunotherapy via ferroptosis activation augmented photodynamic therapy against glioblastoma","author":"Zhang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drup.2025.101326_bib546","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/s41422-023-00879-z","article-title":"FSP1 oxidizes NADPH to suppress ferroptosis","volume":"33","author":"Zhang","year":"2023","journal-title":"Cell Res"},{"key":"10.1016\/j.drup.2025.101326_bib547","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101619","article-title":"The BRD7-P53-SLC25A28 axis regulates ferroptosis in hepatic stellate cells","volume":"36","author":"Zhang","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.drup.2025.101326_bib548","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-025-00750-w","article-title":"Targeting cGAS-STING pathway for reprogramming tumor-associated macrophages to enhance anti-tumor immunotherapy","volume":"13","author":"Zhang","year":"2025","journal-title":"Biomark. Res."},{"key":"10.1016\/j.drup.2025.101326_bib549","doi-asserted-by":"crossref","DOI":"10.1002\/celc.202400666","article-title":"Microfluidic technology: a new strategy for controllable synthesis of metal nanomaterials","volume":"12","author":"Zhang","year":"2025","journal-title":"ChemElectroChem"},{"key":"10.1016\/j.drup.2025.101326_bib550","doi-asserted-by":"crossref","first-page":"1801158","DOI":"10.1002\/adhm.201801158","article-title":"Molecular engineering of functional nucleic acid nanomaterials toward in vivo applications","volume":"8","author":"Zhang","year":"2019","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.drup.2025.101326_bib551","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: a novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2025.101326_bib552","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/s41467-021-21841-w","article-title":"mTORC1 couples cyst (e) ine availability with GPX4 protein synthesis and ferroptosis regulation","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101326_bib553","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.chembiol.2019.01.008","article-title":"Imidazole ketone erastin induces ferroptosis and slows tumor growth in a mouse lymphoma model","volume":"26","author":"Zhang","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.drup.2025.101326_bib554","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12943-024-02224-3","article-title":"CircTTC13 promotes sorafenib resistance in hepatocellular carcinoma through the inhibition of ferroptosis by targeting the miR-513a-5p\/SLC7A11 axis","volume":"24","author":"Zhang","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2025.101326_bib555","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1021\/jacs.4c13241","article-title":"A second near-infrared window-responsive metal-organic-framework-based photosensitizer for tumor immunotherapy via synergistic ferroptosis and STING activation","volume":"147","author":"Zhao","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.drup.2025.101326_bib556","doi-asserted-by":"crossref","first-page":"10771","DOI":"10.2147\/IJN.S535460","article-title":"Nanomaterials Application for STING Pathway-Based Tumor Immunotherapy","author":"Zhao","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.drup.2025.101326_bib557","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.7150\/thno.42564","article-title":"Multifunctional magnetic iron oxide nanoparticles: an advanced platform for cancer theranostics","volume":"10","author":"Zhao","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.drup.2025.101326_bib558","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121988","article-title":"Manganese-enriched photonic\/catalytic nanomedicine augments synergistic anti-TNBC photothermal\/nanocatalytic\/immuno-therapy via activating cGAS-STING pathway","volume":"293","author":"Zheng","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.drup.2025.101326_bib559","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1039\/D0NR08478F","article-title":"Nanoparticle-induced ferroptosis: detection methods, mechanisms and applications","volume":"13","author":"Zheng","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.drup.2025.101326_bib560","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41419-021-03998-w","article-title":"Sorafenib fails to trigger ferroptosis across a wide range of cancer cell lines","volume":"12","author":"Zheng","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drup.2025.101326_bib561","doi-asserted-by":"crossref","first-page":"2301928","DOI":"10.1002\/advs.202301928","article-title":"PGAM1 inhibition promotes HCC ferroptosis and synergizes with anti-PD-1 immunotherapy","volume":"10","author":"Zheng","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.drup.2025.101326_bib562","series-title":"Contemporary Issues in Systems Science and Engineering","author":"Zhou","year":"2015"},{"key":"10.1016\/j.drup.2025.101326_bib563","series-title":"Semin. Cancer Biol","first-page":"89","article-title":"Ferroptosis is a Type of Autophagy-dependent Cell Death","author":"Zhou","year":"2020"},{"key":"10.1016\/j.drup.2025.101326_bib564","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1021\/acsnano.8b00999","article-title":"Nanoenzyme-augmented cancer sonodynamic therapy by catalytic tumor oxygenation","volume":"12","author":"Zhu","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.drup.2025.101326_bib565","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nrclinonc.2011.30","article-title":"HCC and angiogenesis: possible targets and future directions","volume":"8","author":"Zhu","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101326_bib566","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S1470-2045(18)30351-6","article-title":"Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial","volume":"19","author":"Zhu","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.drup.2025.101326_bib567","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1158\/1078-0432.CCR-12-2616","article-title":"First-in-man phase I study of GC33, a novel recombinant humanized antibody against glypican-3, in patients with advanced hepatocellular carcinoma","volume":"19","author":"Zhu","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2025.101326_bib568","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S1470-2045(18)30937-9","article-title":"Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased -fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"20","author":"Zhu","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.drup.2025.101326_bib569","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/s41467-017-02191-y","article-title":"Albumin\/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy","volume":"8","author":"Zhu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101326_bib570","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1186\/s12951-025-03669-4","article-title":"Metal-organic frameworks activate the cGAS-STING pathway for cancer immunotherapy","volume":"23","author":"Zhu","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.drup.2025.101326_bib571","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41592-020-01037-8","article-title":"Spatially resolved single-cell genomics and transcriptomics by imaging","volume":"18","author":"Zhuang","year":"2021","journal-title":"Nat. Methods"},{"key":"10.1016\/j.drup.2025.101326_bib572","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.chembiol.2020.03.015","article-title":"Progress in understanding ferroptosis and challenges in its targeting for therapeutic benefit","volume":"27","author":"Zou","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.drup.2025.101326_bib573","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1053\/j.gastro.2015.05.061","article-title":"Genetic landscape and biomarkers of hepatocellular carcinoma","volume":"149","author":"Zucman-Rossi","year":"2015","journal-title":"Gastroenterology"}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764625001293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764625001293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:47:47Z","timestamp":1773816467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764625001293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":573,"alternative-id":["S1368764625001293"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2025.101326","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ferroptosis and the cGAS\u2013STING pathway into precision nano-immuno-theranostics: A mechanistic paradigm for reversing drug resistance in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2025.101326","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101326"}}